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One thing about trains: It doesn’t matter where they’re going, what 
matters is, deciding to get on.  
       Chris Van Allsburg, The Polar Express 
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ABSTRACT 
Background: During the last 30 years, important changes have been introduced in the management of 
common bile duct stones (CBDS) which can be detected in about 10% of patients undergoing 
cholecystectomy because of symptomatic gallstone disease. Established minimally-invasive treatment options 
for CBDS include endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile 
duct exploration. A complex and demanding situation occurs if conventional ERCP extraction methods fail 
because of the large size and/or the location of the CBDS.  
Objectives: The hypothesis of the thesis were: 1). The peroperative combination of laparoscopy and 
endoscopy, with so-called rendezvous ERCP (RV-ERCP) is by comparison with conventional ERCP, a safe 
and efficient treatment method regarding feasibility in clinical practice, complete stone clearance and ERCP 
associated complications. 2). Extremely large or so-called difficult CBDS can safely and efficiently be 
managed with ERCP assisted peroral cholangioscopy in conjunction with laser lithotripsy (LL) or by 
electrohydraulic lithotripsy (EHL), in order to obtain complete stone clearance.  
Methods: Study I and II are descriptive case series. Study I included patients from 2000 through 2001 at the 
Karolinska University Hospital that was treated with RV-ERCP because of CBDS. Study II included patients 
from 1995 through 2006 recruited from the Karolinska and Östersunds Hospitals, treated with peroral 
cholangioscopy assisted EHL or LL due to difficult CBDS. In study III, patients with symptomatic gallstone 
disease were prospectively enrolled in a comparative case-control study. Patients who underwent laparoscopic 
cholecystectomy were, depending on the peroperative cholangiography results, either treated for CBDS using 
RV-ERCP or assigned to the control group if their cholangiograms were negative. Pancreatic proenzymes 
were analyzed at 0, 4, 8 and 24 hours. Study IV was a nationwide population-based nested case-control study 
within a cohort of 12,718 ERCP investigations selected from the Swedish Registry for Gallstone Surgery and 
ERCP (GallRiks) from 2007 through 2009. The outcome of post-ERCP pancreatitis (PEP) was analysed for a 
number of possible risk factors.  
Results: In study I, 34 patients had a RV-ERCP that was successful in terms of biliary cannulation (100%), 
duct clearance (94%) and no ERCP related complications such as PEP. The operation time was quite long 
(mean 82 min), but the hospital stay was equal to those who were operated with LC alone. In study II, 44 
patients were treated with EHL or LL and overall ductal clearance was achieved in 34 (74%) cases, of which 
13 (30%) patients needed repeated sessions. Large stones (>20 mm) were associated with failure. Old age 
(≥80 years) and poor physical condition did not affect clinical outcomes, and a majority of the patients 
remained free from biliary symptoms for many years at follow-up. In study III, the patients treated with RV-
ERCP and the control group without ERCP, had significantly less pancreatic enzyme leakage, 4 hours after 
the intervention and at later time points, compared with the conventional ERCP group. Inadvertent pancreatic 
duct cannulation and contrast injection into it, were positively associated with higher levels of pancreatic 
enzymes. Among 17,787 patients registered in GallRiks and observed in study IV, 12,718 patients with no 
previous ERCP, were eligible for further analysis. The overall rate of PEP was 3.6%. A 50% reduction in the 
risk of PEP was noted in patients treated with RV-ERCP compared with those who were cannulated by 
conventional means (OR 0.5, 95% confidence interval 0.2-0.9, p = 0.02). Other factors associated with an 
increased risk of PEP were young age, prolonged procedure time and elective ERCP.  
Conclusion: Taken together evidence is hereby provided that RV-ERCP reduces pancreatic damage and 
decreases the frequency of PEP. CBDS identified during LC can safely and effectively be managed by RV-
ERCP in a routine clinical setting. These findings challenge the current management concept of two-step 
ERCP for treatment of CBDS. In addition, ERCP is an efficient and safe first line method in the management 
of difficult CBDS and should be recommended even for old and/or frail patients.  
Keywords: ERCP, common bile duct stones, rendezvous, post-ERCP pancreatitis, electrohydraulic 
lithotripsy, laser lithotripsy.               
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1 HISTORY OF BILIARY STONE DISEASE AND TREATMENT 
 
1.1 HISTORY 
 
It seems that gallstone disease has virtually followed and plagued mankind since the very beginning of human 
history. The earliest evidence of gallstones that we have is from a 4000 year old Stone Age tomb in Gotland, 
Sweden [Mörner 1936], and gallstones were also found in a female Egyptian mummy dating from more than 
3500 years ago [Smith 1906]. Despite the fact that throughout history many physicians, including Hippocrates 
of Cos (460-370 B.C.), Galen of Pergamon (129-216), Alexander of Tralles (525-605), Gentilis Da Foligno 
(died in 1348), Antonio Benivieni (1443-1502), Andreas Vesalius (1536-1564), and Jean Fernel (1497-1558), 
had recognized the presence of the gallbladder, the bile ducts, and gallstones, it was not until 300 years ago 
that scientists started to elucidate the true underlying function and pathology of the gallbladder [Glenn 1971]. 
In the early history of medicine, the state-of-the-art treatment was diet, purgatives, phlebotomy, and emetics 
according to the ancient humoral theory of pathology, with opiates being used against biliary pain. The 
overall prognosis for curing symptomatic biliary stone disease remained poor, and many times the condition 
was fatal. The English anatomist Francis Glisson (1597-1677) summarized his own painful crisis secondary to 
gallstones with the words”only death was the solution for a biliary colic", and his own remedy was to eat 
fresh grass since he observed that cattle after their winter diet of hay and straw had stones in the gallbladder, 
but these ceased to appear after a summer diet of fresh grass [Haeger 1988].  
 
It was not until the second half of the nineteenth century that the first true surgical interventions began to 
appear. The prerequisites for successful surgical procedures were notably improved by several major 
anaesthetic breakthroughs, including the use of ether in 1846 by Thomas Green Morton (1819-1868) and the 
use of chloroform in 1847 by James Young Simpson (1811-1870). In 1859, Johann Thudichum (1829-1901) 
presented a theoretical description of a two-stage procedural approach with transabdominal cholecystostomy 
followed by lithotripsy through the resulting fistula [Thudicum 1859]. It is noteworthy that Thudichum did 
not perform any cholecystostomies himself, but his idea was later adopted by several others surgeons, such as 
Marion Sims (1813-1883) from the U.S.A. [Sims 1878], Theodor Kocher (1841-1917) from Switzerland 
[Kocher 1878] and Robert Lawson Tait (1845-1899) from Great Britain [Shepard 1986]; all three performed 
their first two-step cholecystostomies during 1878. An American surgeon from Indianapolis, John Bobbs 
(1809-1870), became the first to perform a successful elective cholecystotomy in 1867 [Bobbs 1868]. The 
achievement was perhaps more the result of a coincidence since he was operating on a patient for a suspected 
ovarian cyst, but instead found a hydropic gallbladder. Bobbs opened the gallbladder, removed the stones, and 
left the gallbladder in situ after closing the defect.  
 
At a time when surgeons endeavored to construct the perfect gallbladder fistula, the German surgeon Carl 
Langenbuch (1846-1901) stated that his colleagues were busy with the product of the disease, not the cause of 
it. He performed the first cholecystectomy at the Lazarus Hospital in Berlin in 1882 [Langenbuch 1882]. 
Obviously Langenbuch was ahead of his time since many of his contemporary colleagues continued to 
perform cholecystostomies, but the Langenbuch procedure gradually won popularity both in Europe and the 
United States. The first cholecystectomy in Sweden was conducted by Hugo von Unge (1849-1935) in 1889 
[Bolling 1891]. However, it was many years before surgical removal of the gallbladder became the “gold 
standard” for treatment of symptomatic gallbladder disease. There had been several attempts to explore the 
CBD, all of which resulted in the death of the patients, before the first successful CBD exploration was done 
by Knowsley Thornton (1845-1904) in 1889.  
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This was followed shortly by the work of Robert Abbé (1851-1928) in the U.S.A., Ludwig Courvoisier 
(1843-1918) in Switzerland, and Hans Kehr (1862-1916) in Germany. Kehr also invented the rubber T-tube 
(the Kehr tube) for post-operative decompression of the CBD [Morgenstern 1993].  
 
Before the 1930's, only about 1/4 of all patients with symptomatic gallstone disease underwent surgery and 
the procedure was strictly reserved for individuals suffering from severe biliary complications. At this time 
and even much later, most physicians considered the mortality risk to be too high to justify the routine use of 
surgery. Nowadays, with the advent of modern medical care including new surgical techniques, anaesthesia, 
radiology, antiseptics and perioperative care, cholecystectomies can be carried out on routinely basis with low 
morbidity and mortality rates. 
 
The first laparoscopic cholecystectomies were conducted in 1985 by the German surgeon Erich Mühe [Mühe 
1986], followed by Phillipe Mouret in 1987 in France [Spaner and Warnock 1997]. Laparoscopic 
cholecystecomy spread extremely rapidly thoughout the world and gained wide acceptance by surgeons in a 
remarkably short period of time. In 1990, Dag Arvidsson performed the first laparoscopic cholecystectomy in 
Sweden [Arvidsson et al. 1992]. Laparoscopic cholecystectomy has become the gold standard in the 
treatment of biliary disease. In the early 1990’s Petelin described both transcystic and transductal explorations 
[Petelin 1991. The first laparoscopic common bile duct explorations in Sweden were performed in 
1992[Arvidsson et al. 1998]. 
 
A recent development in laparoscopic procedures was the introduction of robotic surgery, including the 
cholecystectomy performed in 2001 by the French surgeon Jacques Marescaux that demonstrated the 
possibilities of this technique. Although Marescaux, as the performing surgeon, was physically in New York, 
he removed a gallbladder from a patient in Strasbourg, France, and thereby carried out the first transatlantic 
tele-surgery [Marescaux et al. 2001].  
 
1.2 THE ADVENT OF ERCP 
 
Transpapillary infusion of radiopaque contrast media into the bilio-pancreatic duct during open operation was 
described by Henry Doubilet and John Mulholland in 1955 [Doubilet and Poppel 1955]. However, the first 
true diagnostic ERCP, which used a long flexible lateral-viewing fiber bundle duodenoscope, was performed 
in 1968 by William McCune (1909-1998) from the U.S.A. [McCune et al. 1968]; he was followed in 1969 by 
Itaru Oi from Japan [Oi 1970]. The first diagnostic ERCP in Sweden was done in 1972 by Lennart Wehlin 
(1922-1983) [Cronstedt 1985]. In 1974, Meinhard Classen and Ludwig Demling (1921-1995) from Germany 
[Classen and Demling 1974] and Keiichi Kawai et al. from Japan [Kawai et al. 1974] independently 
presented their first therapeutic ERCP procedures with sphincterotomy and transpapillary common bile duct 
stone extraction. In Sweden, the first ERCP with sphincterotomy and stone extraction was reported in 1978 
by Gustav Liedberg [Liedberg 1979] and Carl-Erik Nordgren [Nordgren 1979]. A major global change in the 
treatment of CBDS then occurred during the 1990’s when ERCP became the preferred treatment option 
together with laparoscopic cholecystectomy, a combination that allowed the patient the benefits of minimally-
invasive surgery. The two-stage procedure involving pre- or postoperative ERCP together with laparoscopic 
cholecystectomy became the most widespread treatment of CBDS, as it still is today. Simultaneously, ERCP 
lost much of its diagnostic importance during the 1990s when MRCP could produce more information 
without exposing the patient to the risks associated with an ERCP investigation.  
 
As an extension of ERCP, the first orally performed choledocho-pancreatoscopies, which used the mother-
baby technique, were done by Classen and Demling in 1972 [Classen 1972]. Even though first-generation  
intraductal endoscopes were received with scepticism, since the instruments were extremely fragile and 
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expensive and provided pictures of poor quality, they served as an important step in the development of intra-
ductal endoscopy. The latest generation of intra-ductal endoscopy is represented by the SpyGlass System that 
was launched in USA 2006 and in Europe 2007 [Chen and Pleskow 2007, Arnelo et al. 2007, Fishman et al. 
2009, Chen et al. 2011].  
 
In summary, we can recognize the legacy of many pioneers in the field who, during the course of the 20th 
century, advanced the knowledge of biliary stone disease. Inventions like laparoscopy, flexible endoscopy and 
modern radiology, became landmarks that changed the practice of biliary tract surgery. These inventions were 
not just different methods of access; they also represented a different mindset concerning how to approach a 
surgical problem. There have also been great expectations, in part patient driven, which have been greatly 
supported by the medical industry that produced the optical instruments and endoscopic devises that made it 
possible to fulfill these expectations.  
 
1.3 GALLSTONE DISEASE 
 
1.3.1 Formation of gallstones 
The formation of biliary stones is a complex process, and not yet fully understood. In principle, there are three 
types of biliary stones: cholesterol, black pigment, and brown pigment stones. In Western society, about 75% 
of biliary stones are cholesterol, 20% are black pigment and 5% are brown pigment stones [Carey 1993]. 
 
Cholesterol stones 
Cholesterol stones are largely composed of cholesterol monohydrate crystals and are formed in the 
gallbladder from supersaturated bile. The common theme is an unbalance between excessive amounts of 
biliary cholesterol and the secreted amounts of solubilizing bile salts or phospholipids (lecithin). There are 
four major groups of pathophysiological factors that contribute in the formation of cholesterol stones: (1) 
those that lead to supersaturation of the bile, such as genetic expression and  dysregulation of hepatic 
transport proteins [Marschall et al. 2010], (2) those that stimulate cholesterol precipitation and 
chrystallization (mucin formation) [Portincasa et al. 2006], (3) those that result in functional impairment of 
the gallbladder, due to heavy weight loss [Dittrick et al. 2005], diabetes mellitus [Ruhl and Everhart 2000], 
total parental nutrition [Guglielmi et al. 2006] or medication [Attanasio et al. 2008], and (4) those factors that 
lead to a dysfunction of the enterohepatic circulation of bile acids, such as gastric bypass surgery [Reshetnyak 
2012]. 
 
Black pigment stones 
 
Black pigment stones are formed in the gallbladder by acid salts of calcium bilirubinate, calcium carbonate, 
and calcium phosphate in polymer-like complexes together with mucin glucoproteins [Bar Dayan et al. 
2004]. Bilirubin, a breakdown end product of haemoglobin, is conjugated in the liver in different steps and 
secreted into the bile as water-soluble bilirubin diglucuronide. However, unconjugated bilirubin is poorly 
water-soluble and in situations of excessive haemolysis, biliary excretion of unconjugated bilirubin may 
increase the risk calcium bilirubinate precipitation. Formation of black stone pigment stone is, for example, 
associated with chronic haemolytic diseases like sickle cell anaemia, hereditary spherocytosis, Guilbert 
syndrome, and cirrhosis. Another example of excessive bilirubin in bile can be observed among patients with 
increased recycling of bilirubin in the bowel, such as patients suffering from Crohn’s disease with an affected 
or resected distal part of the ileum.  
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Brown pigment stones 
 
Unlike the others, brown pigment stones are formed in the bile ducts as a consequence of a chronic bacterial 
or parasite infection. Bacteria such as Escherichia coli, Bacteroides, and Clostridium species, promote 
enzyme activity through hydrolysis of bile salts, resulting in unconjugated bilirubin, palmitic and stearic 
acids, and unconjugated bile acids, which can form complexes with calcium and lead to subsequent stone 
formation [Vitek and Carey 2012]. Intraductal infestation of parasites such as Ascaria lumbricoides, 
Clonorchis sinensis, Opistorchis, and Fasciola species can produce a calcified overcoat of the parasite egg 
that serves as a nidus for the precipitation of calcium bilirubinate. 
 
Biliary sludge and microliths 
 
Hypersecretion of gallbladder mucin promotes nucleation of cholesterol crystals or bilirubinate salts in the 
gallbladder. This mud or gel-like suspension, called biliary sludge, reduces the buffering capacity of bile acids 
and is believed to be an essential stage in the formation of both cholesterol and black pigment stones. Biliary 
sludge contains comparatively large particles (1-3 mm) called microliths. Microlithiasis and sludge may cause 
biliary pain and cholecystitis cholangitis [Jüngst et al. 2006], but if it is a causative etiology for acute 
pancreatitis remains controversial. Several studies have shown the presence of biliary sludge in as many as 
75% of patients with unexplained acute pancreatitis.  
 
Impaired motility in the gallbladder  
 
Normally, one or two hours after meal ingestion, the gallbladder has emptied up to 70% or 80% of its 
contents as a response to the hormone CCK, which is released from the upper intestine. However, it is during 
the state of fasting that gallstone formation is likely to occur, especially during the night when biliary 
cholesterol saturation and secretion is high and bile salt secretion is low. Excessive amounts of cholesterol are 
incorporated in the sarcolemma plasma membranes of the gallbladder muscle cells, resulting in relaxation and 
decreased contractility. Impaired gallbladder emptying prolongs the residence of bile in the gallbladder, 
allowing more time for nucleation of cholesterol crystals from supersaturated bile. Microscopic crystals that 
might have been ejected to the common bile duct if the gallbladder had functioned normally are instead 
retained and grow in size. Although impaired gallbladder motility is secondary to cholesterol supersaturation, 
it may secondarily promote the process of gallstone formation [Dittrick et al. 2005]. 
  
 
1.3.2 Epidemiology of gallstone disease 
 
The prevalence of gallstone disease varies globally among different ethnic populations, ages and genders. In 
Western society, biliary stone disease is present in approximately 5% - 25% of adults [Halldestam et al. 2004, 
Bates et al. 1992]. Epidemiological data derived from Scandinavian population sources have shown an 
overall prevalence ranging from 11% - 55% in females and 4% - 25% in men (the higher rates were found in 
autopsy investigations [Wenkert and Robertson 1966, Torvik and Hoivik 1960] and the lower rates were 
obtained from ultrasonography screening [Janzon et al. 1985, Mellström et al. 1988, Muhrbeck and Ahlberg 
1995]). Populations with an overall low prevalence of gallstone disease are found in Asia and in Africa (<5%) 
[Walker et al. 1989, Kratzer et al. 1999]. In contrast, an extremely high prevalence can be found in Native 
American Indian population such as the Pima Indians in Arizona, who have an overall prevalence of 46% 
[Sampliner et al. 1970].  
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The prevalence of gallbladder disease correlates positively with age and female gender. Gallstones seldom 
occur in childhood; they begin to appear more frequently in adolescence (age < 30 years; male 2% to 4%: 
female 5% to 6%). Prevalence increases markedly between the ages of 40 to 60 years (60 years; male 13% to 
37% : female 20% to 40%) and continues to rise gradually in higher ages (70 years; male 19% : female 30%) 
[Jørgensen 1987, Glambek et al. 1987]. In females in their 80’s, up to 50% have gallstones or have previous 
undergone cholecystectomy [Mellström et al. 1988]. Females with previous multiple full-term pregnancies 
[Jørgensen 1987, Ko et al. 2005] and those who have received exogenous estrogen therapy [Cirillo et al. 
2005] seem to have a higher prevalence of gallstone disease.  
 
1.3.3 Natural history of biliary stone disease 
 
The vast majority of individuals with gallstones are completely asymptomatic and will continue to be so 
throughout their lives. In previous studies, nearly two-thirds of patients with biliary stones were referred to as 
asymptomatic [Janzon et al. 1985, Jørgensen 1989] and in other epidemiological reports up to 80% - 90% of 
the stone carriers were characterized as asymptomatic [Angelico et al. 1997, Barbara et al. 1987, Berger et al. 
2000]. The reason why gallstones give rise to symptoms in one patient and not in another remains obscure; 
there is no evidence that silent stones differ in number, size, or composition from symptomatic stones 
[Bouchier et al. 1968]. The increasing use of radiology in clinical practice has produced incidental detection 
of gallstones.  Many of these patients can experience various forms of indigestion and abdominal discomfort 
that are not normally associated with biliary disease. Dyspeptic symptoms like belching, flatulence, nausea, 
intolerance to fatty food, bloating of the abdomen, epigastric discomfort and acid regurgitation, have been 
shown to be as common in individuals without gallstones as in individuals with biliary stones [Muhrbeck and 
Ahlberg 1995, Borch et al. 1998]. Studies of the natural history of asymptomatic gallstones suggest that the 
cumulative probability of developing biliary colic after ten years ranges from 10% - 30% and symptoms 
requiring surgical treatment occurred in 1.3% -3.0% annually [Gracie and Ransohoff 1983, McSherry et al. 
1985]. For patients with asymptomatic gallstones, the natural history is so benign that cholecystectomy is not 
recommended (RG: B). This recommendation includes patients at risk such as diabetic patients [Del Favero 
et al. 1994], patients submitted for obesity surgery [Plecka Östlund et al. 2012], children in general, and 
children with sickle cell disease [Gummiero et al. 2008]. Studies have suggested that complications are less 
likely the longer the stones have remained asymptomatic [Attili et al. 1995].  
 
 
1.3.4 Symptoms of gallbladder stones and aspects of management 
 
Symptomatic gallstones without complications 
 
Biliary colic is defined as a steady right upper quadrant abdominal pain lasting for more than half an hour, 
which may be associated radiation to the back and nausea and may force patients to stop their activities 
[Berger et al. 2000]. The distinction between symptomatic and asymptomatic gallstones and the timing of 
when to perform cholecystectomy are controversial subjects. Several reports suggest wait-and-see 
management after the first day of illness until further symptoms or more severe complications are present 
[Ransohoff and Gracie 1993, Friedman et al. 1989, Vetrhus et al. 2002], while others recommend early 
cholecystectomy once symptoms have started, based on several longitudinal studies demonstrating a 
reduction of medical costs and morbidity for patients with early surgical intervention [Rutlegde et al. 2000, 
Somasekar et al. 2002, Sobolev et al. 2003] (EG: III, RG: B).  
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Manifestations of cholecystitis 
 
If a gallstone obstructs the outlet of bile from the gallbladder, pressure gradually increases within the 
gallbladder and an inflammatory process is established [Jivegård et al. 1987]. Typically it begins with a 
biliary colic type of pain with tenderness under the right subcostal margin, but it does not settle down until 
one or more days. Laboratory examinations are not specific for the diagnosis, but C-reactive protein (CRP) 
and the white blood cell count (WBC) are usually elevated. Occasionally, a mild jaundice can be noticed with 
elevation of liver transaminase and bilirubin, probably due to peribiliary edema surrounding the gallbladder. 
However, CBDS may be present in approximately 20% of the cases and even more frequently among elderly 
patients [Claesson et al. 1984]. Bacterial infection of the bile is relatively less important in the early phase of 
acute cholecystitis [Järvinen 1980]. Older age [Glenn and Dillon 1980], diabetes mellitus [Hickman et al. 
1988], CBDS, and previous biliary surgery [Wells et al. 1989] are known to be risk factors that are associated 
with positive bacterial cultures. Most surgeons recommend cholecystectomy after a first bout of cholecystitis 
(RG: B) [Rutlegde et al. 2000, Somasekar et al. 2002, Sobolev et al. 2003, Friedman et al. 1989, Johansson et 
al. 2003], even for elderly patients [Edlund and Ljungdahl 1990], since that is associated with a shorter 
hospital stay and cost savings (RG: A) [Gurusamy and Samray, Wilson et al. 2006]. In severely ill or fragile 
patients, ultrasonically-guided percutaneous catheter drainage of the gallbladder (cholecystostomy) with 
broad-spectrum antibiotics may be an alternative choice for treatment for those who are not suited for 
abdominal surgery (RG: A) [Gurusamy and Davidson 2010a].  
 
Acute gangrenous cholecystitis and emphysematous cholecystitis are serious variants of acute cholecystitis 
with rapid formation of gas-forming organisms penetrating the gallbladder wall into the surrounding area, 
which severely increases the risk of serious outcome and mortality [Nikfarjam et al. 2011]. Gallbladder 
perforation or empyemas are other critical features that call for emergency cholecystectomy or 
percutaneous/transhepatic cholecystostomy [Al-Jundi et al. 2012].  
 
Chronic inflammation with bilio-enteric fistula formation is a rare condition that is associated with elderly 
patients who have large gallstones that erode into the adjacent duodenum and, if large enough, cause a 
mechanical obstruction in the intestinal lumen [Reisner and Cohen 1994] that calls for an emergency 
laparotomy with enterolithotomy. Even though controversy remains, cholecystectomy and repair of 
cholecysto-enteric fistula are recommended to be done later only if there are continuing or recurrent 
symptoms [Shenoy and Cassim 2010]. 
 
The Mirizzi syndrome is a rare, chronic inflammatory condition that can be classified in subtypes [Mirizzi 
1948, Csendes et al. 1989].  Type I is limited to an impacted large gallstone in the cystic duct or in the neck 
of the gallbladder that mechanically compresses the adjacent CBD running parallel to the cystic duct, 
gradually resulting in complete or partial obstruction of the CBD. Type II involves the formation of a bilio-
biliary fistulation into the CBD by the impacted stone.  
 
1.3.5 Common bile duct stones (CBDS) 
 
Etiology 
 
In Western countries, the majority of CBDS are secondary since they are originally formed in the gallbladder 
by cholesterol or more seldom by bilirubin and migrate through the cystic duct. The diameter of the cystic 
duct (>4mm) seems to play a critical part in the migration of stones [Taylor and Armstrong 1987]. Primary 
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CBDS are more common in South Asia and are associated with parasitic infection or superimposed bacterial 
infections. Primary CBDS formation of infectious origin can also be seen in patients with duodenal 
diverticula, bile duct strictures from various causes, and foreign bodies such as stents and suture remnants.   
 
1.3.6 Symptomatology and aspects of management 
 
Asymptomatic common bile duct stones 
 
The natural history of CBDS is not as fully understood as that of stones in the gallbladder. It is a well-
recognized fact that approximately 25% of patients with CBDS are more or less asymptomatic and a 
substantial number of these (30% to 50%) will eventually pass their CBDS spontaneously and silently. 
Furthermore, it is unclear what stone size will actually permit passage or why some stones leave silently into 
the duodenum whereas others do not. In addition, one must also consider the critical functional role of the 
sphincter of Oddi in passing or retaining CBDS [Vracko and Wiechel 1999]. This somewhat haphazard 
circumstance is reflected in several important clinical situations, for example, during elective 
cholecystectomy, where the prevalence of unexpected CBDS can be as high as 4% to 10%. Another example 
is the disappearance of CBDS during the time between radiological detection and the following intervention, 
e.g. ERCP or a cholecystectomy. The prevalence of existing CBDS at the time of intervention may be as low 
as 10% - 20% [Neuhaus et al. 1992, Saltzstein et al. 1982, Houdart et al. 1995]. In an increasingly litigious 
society, most physicians would recommend removal of a detected asymptomatic CBDS for the fear of 
subsequent complications that may ensue, especially since asymptomatic stones tend to develop 
complications rather than symptoms [Caddy and Tham 2006]. What is clear, however, is that once a stone has 
revealed itself with symptoms, it will always represent a potential danger for the patient and consequently 
needs to be taken care of [Besselink et al. 2009] (EG: III, RG: B).  
 
Obstructive jaundice  
 
Partial or complete obstructive jaundice can develop as a consequence of CBDS. Obstructive jaundice may 
lead to secondary fatal consequences such as cholangitis, renal dysfunction, cardiovascular dysfunction and 
coagulopathy. Indissoluble obstruction of the biliary outflow will eventually lead to secondary biliary 
cirrhosis and portal hypertension [Williams et al. 2008]. 
 
Acute cholangitis 
 
Acute cholangitis is a severe suppurative infection that affects the bile ducts, usually from bacteria ascending 
from the duodenum, and it is often associated with biliary outflow obstruction. Clinical signs are jaundice, 
fever, and upper right abdominal pain. If the condition fails to respond to antibiotic therapy or deteriorates 
into septic shock, it should be considered as an emergency situation that could pose an immediate threat to the 
patient if not treated with biliary decompression by either ERCP or PTC  (EG: Ib, RG: A) [Lai et al. 1992]. 
 
Acute biliary pancreatitis 
 
Common bile duct stones are by far the most common cause of acute pancreatitis in Western society and 
account for about 30% - 60% of all cases [Lowenfels et al. 2009]. Small stones, which are prone to be trapped 
in the narrow ampulla, or stones that occur in high numbers that might allow repetitive obstructions are 
typical risk factors associated with acute biliary pancreatitis [Taylor and Armstrong 1987, Dihel et al. 1997]. 
The severity of acute pancreatitis seems to be proportional to the duration of the pancreatic duct obstruction, 
and persistent bilio-pancreatic occlusion is associated with a more severe outcome [Senninger et al. 1986, 
Rünzi et al. 1993, Lerch and Aghdassi 2010]. These observations may provide a rational for early attempts to 
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decompress the intraductal pressure by removing an obstructive stone in the early stage of the disease and 
removing the threat of additional remaining CBDS. Nevertheless, the current opinion is that early (<48 hours) 
ERCP with sphincterotomy may be useless. Because several clinical studies have shown a 71–88% rate of 
spontaneous disobstruction within 48 hours after the onset of acute biliary pancreatitis, only a relatively small 
subgroup of patients might, in fact, have a theoretical justification for undergoing early ERCP with 
sphincterotomy [Petrov 2009] (EG: Ib, RG: A). Only patients with co-existing acute cholangitis or sepsis and 
those with a persistent CBD obstruction (<72 hours) may benefit from early ERCP intervention [Forsmark 
and Baillie 2007] (EG: Ib, RG: B). ERCP intervention beyond 72 hours of the onset of illness, does not 
produce any benefit, thus raising a concept of a therapeutic window [Acosta et al. 2006].  
 
There are different opinions of how to prevent patients from subsequent relapses of biliary pancreatitis. No 
treatment at all or a wait-and-see policy is associated with a potential risk of having a relapse that is estimated 
to be up to 50% to 90% [Kelly and Swaney 1982, Uomo et al. 1997, Trust et al. 2011]. Consequently, 
conservative management is not to be regarded as an acceptable treatment.  
 
If the gallbladder is removed, the risk of having another relapse of biliary pancreatitis should be very low 
[Frakes 1999]. A prospective study with a follow-up time of 34 months has found recurrence rate of 2.4% 
after surgery [Kaw et al. 2002]. The current recommended policy is to perform a cholecystectomy as soon as 
possible after an attack of biliary pancreatitis, preferably within the same hospital stay or at least within 2 to 4 
weeks after discharge to prevent relapses of acute pancreatitis (EG: Ib, RG: A).  
 
Endoscopic sphincterotomy is an effective therapeutic approach for reducing the risk of relapsing biliary 
pancreatitis close to 2%-4%, but not from late gallbladder-related complications [Hammarström et al. 1998, 
Vázques-Lglesias et al. 2004]. A prospective randomized Dutch multicenter trial reported that a wait-and-see 
policy after endoscopic sphincterotomy could not be recommended as a standard treatment since 47% of the 
expectantly-managed patients developed recurrent biliary events within the 2-year follow-up period, 
compared with 2% in the prophylactic cholecystectomy group, and up to 37% in the deferral group needed 
cholecystectomy on demand [Boerma et al. 2002]. Therefore, cholecystectomy is strongly recommended 
after an attack of gallstone pancreatitis (RG: A) [Gurusamy et al. 2010b].  
 
However, in patients who are considered to be unfit for surgery for any reason, sphincterotomy can provide 
acceptable protection from future attacks of biliary pancreatitis. The same applies to patients who need an 
extended recovery time after a severe attack of pancreatitis, in whom a cholecystectomy can be performed 
safely when their general condition improves.  
 
 
1.3.7 Diagnosis of common bile duct stones 
 
Choledocholithiasis is often suspected in patients who have elevated liver function test results, jaundice, 
pancreatitis, radiologic signs of dilated intra- or extra-hepatic ducts, or evidence of common bile duct stones 
either by transabdominal ultrasound (US), computed tomography (CT), magnetic resonance (MR), 
endoscopic ultrasonography (EUS), or cholangiography. ERCP can also be perceived as a diagnostic tool for 
confirming the presence of CBDS, but given the risk of complications, these other diagnostic modalities 
should be utilized instead of ERCP (EG: IIb, RG: B) [Williams et al. 2008].  
 
 
 
 
20 
Biochemical tests 
 
Various clinical indicators and combinations of biochemical tests such as serum bilirubin, alanine  
aminotransferase (ALAT) and aspartate aminotransferase (ASAT), alkaline phosphatase (ALP), gamma 
glytamyl transpeptidase (GGT) have been suggested as valuable cholestatic liver function parameters for 
predicting CBDS in clinical practice [Anciaux et al. 1986, Yang et al. 2008]. Data from prospective studies 
are inconsistent, and it appears that no single biochemical marker or combination of markers can currently 
provide a reliable test for predicting CBDS. Several promising attempts have been made to compensate for 
this lack of prediction by making sophisticated risk assessment nomograms or scoring system analyses based 
on various preoperative data [Menezes et al. 2000, Taylor 1988, Trondsen et al. 1998]. However, these have 
never really gained acceptance in clinical practice since they tend to be too complicated to use or unreliable. 
A previous consecutive study of 1390 cholecystectomies by Rieger et al [Rieger and Wayand 1995], showed 
a 60% accuracy of concomitant CBDS when the assessment was based on altered liver chemistries alone, 
69% when liver chemistries were combined with radiological abnormalities, and 42% when radiologic criteria 
of CBDS were used alone. Another study by Videhult et al [Videhult et al. 2011], which included 1171 
cholecystectomies in a prospective population-based trial, found CBDS in 42% of patients with elevated liver 
function values, in 20% with a history of acute pancreatitis and in 9% with acute cholecystitis. The 
association between elevated liver function values and CBDS was somewhat stronger in patients scheduled 
for elective cholecystectomy compared with emergency cases. Nevertheless, the risk for CBDS was only 6% 
when liver function test was normal for ALP and bilirubin [Cohen et al. 2001].  
 
Transabdominal Ultrasonography 
 
Transabdominal ultrasound is generally used as a screening test in the diagnosis of gallbladder stones; 
however, it is not extremely sensitive in the detection of CBDS (sensitivity 36%, specificity 98%) [Stott et 
al.1991]. Nevertheless, ultrasonography in combination with clinical symptoms and laboratory abnormalities 
is a safe and convenient first line of investigation for selecting patients who may need further imaging (EG: 
III, RG: B). 
 
Endoscopic Ultrasonography (EUS) 
  
Endoscopic ultrasonography (EUS) is an accurate test for detection of CBDS, with a sensitivity and 
specificity of greater than 90% [Garrow et al. 2007]. EUS can also be valuable diagnostic modality in 
detecting cholecystolithiasis, sludge or microlithiasis and in identifying the presence of lodged stones in 
papillary region in the early phase of acute biliary pancreatitis [Tandon and Topazian 2001, De Lisi et al. 
2011]. EUS is a safe investigation and should be considered a low-risk alternative to ERCP, especially in 
cases with low to moderate likelihood of CBDS (EG: IIb, RG: B). However, EUS is a user-dependent 
technique and cannot clearly identify stones above the common hepatic duct [Gupta et al. 2008]. 
 
Intraoperative Laparoscopic Ultrasonography (ILUS) 
 
Intraoperative laparoscopic ultrasonography has been used increasingly instead of IOC over the last years as 
screening methods of choice to identify the presence of CBDS during ongoing cholecystectomy. Results are 
promising and ILUS seems to be a reliable method in experienced hands with a success rate close to 95% 
together with a high sensitivity and specificity comparable with IOC [Nasu et al. 2012]. Compared with IOC, 
however, there is a considerate learning curve to overcome and ILUS is considered to be inferior to delineate 
bile duct anatomy and duct anomalies.  
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Computed tomography (CT) 
 
Trials with conventional computed tomography (CT) [Mitchell and Clark 1984] or unenhanced CT [Neitlich 
et al. 1997] have reported an approximate sensitivity of 80% and specificity around 90% in the detection of 
CBDS [Lee et al. 2006]. Oral enhanced CT cholangiography has shown a higher sensitivity of 92% [Soto et 
al. 2000]. CT scans are commonplace and are useful in the management of patients with obscure abdominal 
symptoms. However, CT is not justified as a routine method for the diagnosis of CBDS prior to 
cholecystectomy, due to its low positive predictive value and the exposure to radiation that is involved.  
 
Magnetic Resonance Cholangiopancreatography (MRCP) 
 
Magnetic resonance cholangiopancreatography (MRCP) has become an accepted substitute for diagnostic 
ERCP.  MRCP has a high sensitivity (85%-95%) and specificity (90%-100%) for CBDS down to the size of 3 
mm [Lendro-Cano 2006]. MRCP is not operator-dependent, and all liver segments and the complete extra 
hepatic duct system and the pancreatic duct can be visualized. Despite good results, MRCP cannot be 
recommended as a routine investigation for CBDS detection in unselected patients owing to its high cost and 
limitations of resources. However, MRCP should always be prioritized over ERCP in cases with low 
probability of CBDS or in cases where one would expect technical endoscopic difficulty in performing 
endoscopy [Holzknecht et al. 1998]. 
 
Intravenous cholangiography (IVC) 
 
The purpose of using preoperative intravenous cholangiography (IVC) is to select patients with CBDS who 
should undergo preoperative ERCP or intraoperative cholangiography and thereby reduce operating time in 
the following LC [Dorenbusch et al. 1995]. However, reported experiences have yielded contradictory 
results, demonstrating that the use of routine IVC exposes the patient population to a large radiation burden 
and that the cost is high for the relatively small number of patients who may benefit, since the sensitivity is 
too poor. Moreover, it does not seem to be helpful in reducing the incidence of operative bile duct injuries 
during LC [Järhult 2005].  
 
Intraoperative cholangiography (IOC) 
 
Intraoperative cholangiography (IOC) is the gold standard for detecting CBDS during laparoscopic or open 
cholecystectomy. The sensitivity, specificity, and positive and negative predictive values of IOC in detecting 
common bile duct stones are higher than 95% [Videhult et al. 2009]. The procedure is safe and can be 
performed routinely on 97% to 99% of patients, without any preoperative preparation [Sackier et al. 1991]. 
IOC offers an immediate “real-time” CBDS imaging that allows treatment to be performed as a single 
operative procedure. Large population-based studies have shown that IOC not only detects stones but also 
permits delineation of the operative bile duct anatomy, thereby decreasing the incidence of inadvertent bile 
duct injuries by 34% [Waage and Nilsson 2006] to 70% [Flum et al. 2003]. Nevertheless, there are those who 
are questioning whether IOC is worth the effort, operation time, and cost to detect asymptomatic CBDS, 
particularly in patients who in whom the suspicion of CBDS is low, and are therefore reluctant to perform 
IOC routinely in all patients [Clair et al. 1993]. Some people refer to the natural history of asymptomatic 
stones, which shows that the majority of stones leave spontaneously and suggest that it is acceptable to use 
subsequent ERCP to treat the few percentage of stones that may lead to symptoms [Gerber and Apt 1982].  
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However, the frequency of referred patients with post-laparoscopic cholecystectomy complications from 
retained stones may be more common than some other investigators have suggested [Cuschieri et al. 1994]. 
The controversy is complicated by the fact that no study has yet been completed to determine the true 
outcome of stones intentionally left in the CBD. 
 
 
1.3.8 Surgical treatment of common bile duct stones 
 
If CBDS are detected during the course of a LC, there are basically three different modalities of procedures: 
1) complete laparoscopic management (transcystic or choledochotomy) (EG: Ib, RG: A), 2) conversion to 
open surgery with common bile exploration (EG: III, RG: B), or 3) endoscopy, either by intra-, pre- or post-
operative ERCP (EG: Ib, RG: A) [Williams et al. 2008]. 
 
1.3.9 Laparoscopic or open common bile duct exploration  
 
Laparoscopic transcystic common bile duct exploration (LTCE) 
  
LTCE is a method in widespread use because it can be conducted quickly, it is relatively easy to learn, and it 
can be performed at a low expense [Lyass and Phillips 2006]. Results based on one-center case series show 
that LTCE is applicable in about 58% to 92% of the cases. Quoted rates of stone clearance after LTCE are 
reported between 65% to 95% and rates of retained CBDS are reported in approximately 5% [Petelin 2003, 
Paganini et al. 2007, Strömberg et al. 2008a]. If there is doubt whether complete stone clearance has been 
obtained, transcystic drainage is usually inserted and checked postoperatively with secondary 
cholangiography.  
 
Laparoscopic common bile duct exploration (LCBDE) 
 
Laparoscopic choledochotomy has a high success rate, from 85% to 92% and is not limited by the size of 
stones [Petelin 2003]. However, laparoscopic choledochotomy has its own share of complications; morbidity 
rates around 10% and mortality less than 1% have been reported. Some of the morbidity can be attributed to 
the placement of a T-tube. There are people who advocate alternative techniques with primary suture of the 
incision without using a T-tube or who use a transcystic duct tube or biliary endoprothesis instead. Mean 
hospital stay is approximately 2 to 9 days. LCBDE adds approximately 60 to 100 minutes or more to the 
cholecystectomy operation time, depending on the complexity of the case [Costi et al. 2010, Elgeidie et al. 
2011b].  
 
Open common bile duct exploration, choledochotomy 
 
Although open common bile duct exploration is performed very seldom today because of the success of stone 
removal by ERCP or laparoscopic techniques, there are still several indications for open exploration. The 
most obvious example is patients who are undergoing another open abdominal procedure or when a 
laparoscopic procedure is converted to an open one. Other indications for an open approach are large or 
multiple CBDS that may be difficult to remove by ERCP or the suspicion of Mirizzi syndrome. In these and 
other cases, the decision should be based on the estimated risk of alternative strategies. After removal of 
CBDS, the closure of the opening can be done with a protective T-tube or without a tube (primary repair). A 
T-tube offers decompression of the biliary outflow obstruction due to residual stones or edema and to obtain 
postoperative (secondary) cholangiography before removal of the T-tube. If there is a need for subsequent 
biliary treatment, the T-tube can act as a connection to the common bile duct. However, the T-tube cannot 
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usually be removed before 10-14 days after surgery, and there is a risk of intraabdominal infection, bile 
leakage and peritonitis after tube removal. Exploring the CBD during open cholecystectomy seems to add 
little to the risk of mortality in patients with low risk from surgery (< 1% for patients under 60 years), but it 
does, however, increase mortality in patients aged over 60 years (1.8%-4.7%) [Morgenstern et al. 1992, 
McSherry 1989].  
 
 
1.3.10  Endoscopic treatment of common bile duct stones  
 
Endoscopic retrograde cholangiopancreatography (ERCP) 
 
In Western society today, ERCP is the dominating therapy in the management of CBDS. Principally the 
procedure consists of cannulation of the papilla, followed by cutting of the sphincter of Oddi and then stone 
removal.  
 
Cannulation  
 
Cannulation is usually a straight-forward, swift procedure in the hands of an experienced endoscopist. Deep 
cannulation is a prerequisite for any therapy during ERCP, and failure to achieve ductal access leaves the 
disease untreated. When the duodenoscope is positioned into a short loop facing the papilla, cannulation is 
conducted using various accessories and techniques; however, the safest and most effective approach has yet 
to be determined. The wire-guided cannulation technique (WGC), figures 2 and 3, which uses a standard 
triple-lumen sphincterotome together with a hydrophilic guidewire, appears to be gaining acceptance as an 
efficient device for biliary access (RG: A) [Freeman and Guda 2005, Karamanolis et al. 2005, Zhou et al. 
2006, Bailey et al. 2008].  
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The traditional contrast guided (CGC) technique has the 
potential disadvantage that contrast medium may end up in 
the main pancreatic duct, an event that could promote 
development of PEP, figure 4. On the other hand, WGC 
may traumatize the papilla or the pancreatic duct by direct 
injury from the tip against the ductal epithelium, especially 
in the case of repeated contact.  Inadvertent pancreatic 
opacification may be possible if the guidewire is introduced 
unintentionally into the pancreatic duct, which was 
mistaken for the CBD.  
 
RCT trials have found that biliary cannulation with or 
without WGC technique can be performed with equivalent 
results for successful cannulation, but it is not entirely clear 
whether WGC technique reduces the risk of PEP. 
However, a meta-analysis by Cennamo et al [Cennamo et 
al. 2009] concluded that the WGC technique increased the 
primary cannulation rate by 10 % (85 % versus 75 %) 
compared with CGC. WGC also reduced both the number 
of difficult cannulations and the use of the pre-cut 
technique. These findings may also explain why the investigators could show a significant reduction in PEP 
(OR 0.23, 95% CI 0.13 – 0.41).  
 
Nevertheless, in daily practice, both cannulation techniques may be used as crossover methods if the other has 
failed, thereby producing a cumulative increase in risk as a result of excessive papillary trauma and pancreatic 
duct injections. A circumstance that also prevails in the prospective randomized”cross over” trials that did not 
demonstrate a reduced risk of pancreatitis [Mariani et al. 2012, Bailey et al. 2008]. 
 
Endoscopic sphincterotomy (EST) 
 
Cleavage of the papilla and the sphincter of Oddi is done 
in order to obtain biliary access and space for stone 
extraction and to prevent further stone obstruction, figure 
5. One of the early controversies concerning the use of 
ERCP was the need to perform endoscopic biliary 
sphincterotomy. As a precautionary measure, sphinctero-
tomy was only advocated for elderly or frail patients with 
other co-morbid illness that excluded them for surgical 
treatment or for patients with a history of previous 
cholecystectomy. In such patients, the relatively low rate 
of serious complications was clearly a major advantage 
compared with surgery. However, increased use of 
sphincterotomy in younger patients led to a serious 
concern about long-term sequele of the chronic enteric-
biliary reflux that occurred following permanent disruption 
of the barrier between the duodenum and the duct system. 
The potential problems discussed included cholangitis 
cholecystitis infectious stone recurrence biliary strictures, 
biliary pain [Bergman et al. 1996, Costamagna et al. 2002, 
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Hawes et al. 1990], and ultimate development of cholangiocarcinoma [Tanaka 2002]. However, data from 
almost 40 years of experience with sphincterotomy have not supported many of the worst apprehensions 
mentioned above [Karlson et al. 1997, Schreurs et al. 2002, Strömberg et al. 2008b] and patients suffering 
from benign recurrent biliary complications can be managed endoscopically [Costamagna et al. 2010]. 
Instead, the indications for endoscopic sphincterotomy have been broadened, and sphincterotomy is now 
offered to most patients, regardless of age [Sugiyama and Atomi 1998, Tham et al. 1997]. Other procedure-
related complications like bleeding, perforation, cholangitis, and pancreatitis, are all discussed separately 
later. Most published data suggest that significant complications occur in about 4% to 15% of patients after 
sphincterotomy, with an overall mortality of about 0% to 1.5% [Cotton et al. 2009, Christensen et al. 2004, 
Cheng et al. 2006].  
 
Endoscopic papillary balloon dilatation (EPBD) 
 
A compelling reason for not using sphincterotomy is that sphincter function is permanently damaged by 
endoscopic biliary sphincterotomy, whereas the choledocho-duodenal pressure gradient is restored 
immediately after EPBD [Isayama et al. 2003]. A number of prospective trials have compared EPBD with 
sphincterotomy, and overall complication rate was about the same between the two methods [Ochi et al. 
1999, Vlavianos et al. 2003], with the important exception that some trials reported a significant higher 
incidence of severe PEP after EPBD and subsequent death due to pancreatitis [Bergman et al. 1997, Arnold et 
al. 2001, Fujita et al. 2003]. Since endoscopic sphincterotomy is associated with a relatively low 
complication rate, there is almost no margin for improvement for EPBD, and EPBD is not recommended in 
routine ERCP practice (EG: Ia, RG: A).  
 
Difficult cannulation 
  
Difficult cannulation refers to the situation where there are major difficulties in entering the bile duct with 
regular cannulation methods. Some studies have aimed to provide specific criteria for defining a difficult 
cannulation. These include repeated cannulation attempts (5 or 10 attempts) [Lee et al. 2009], extension of 
cannulation time (10 or 30 minutes) [Lee et al. 2009, Zhou et al. 2006, Katsinelos et al. 2008, Laasch et al. 
2003, Maeda et al. 2003, Kaffes et al. 2005], repeated guidewire passages or contrast injections into the 
pancreatic duct (3 or 5 times) [Zhou et al. 2006, Kaffes et al. 2005], the necessity of resorting to pre-cut 
cannulation methods, or complete failure. However, despite attempts to standardize these values, there are no 
established thresholds to determine at what point a cannulation is termed difficult [Löhr et al. 2012]. Even 
with experienced endoscopists and effective primary cannulation techniques, the rate of difficult cannulations 
remains approximately around 10% to 30% among unselected cases of non-sphincterotomized patients, 
depending on how the difficult cannulation is defined [Udd et al. 2010]. Irrespective of the technique used, 
primary cannulation failure rates in most studies are up to 10%, declining to less than 1% at a second or third 
ERCP attempt [Kim et al. 2012, Kumar et al. 1995]. The reason for the great interest in trying to define 
difficult cannulation is that difficult cannulation probably represents the single most important risk factor that 
may cause ERCP-related complications such as PEP [Freeman et al. 1996]. The risk of PEP after difficult 
cannulation is approximately 11% to 15%, compared with a rate of 3% to 4% for a standard non-difficult 
cannulation. [Freeman et al. 2001, Vandervoort et al. 2002]. Possible reasons for the increased risk may be 
prolonged ampullary manipulation, resulting in tissue oedema of the pancreatic sphincter and repeated 
traumatization or opacification of the pancreatic ductal system [Masci et al. 2001, Vandervoort et al. 2002, 
Bailey et al. 2008].  
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Pre-cut sphincterotomy 
 
Pre-cut biliary sphincterotomy with the use of a needle-knife sphincterotome is perhaps the most commonly 
used approach for overcoming a difficult cannulation [Siegel 1980]. It can be performed by two basic 
approaches: needle-knife papillotomy or supra-papillary fistulotomy, figure 6 and 7. 
 
 
 
Both methods provide equivalent results for successful cannulation (90% to 96%) and for complication rates 
of about 2% to 13% [Gullichsen et al. 2005, Abu-Hamda et al. 2005]. The question of whether the pre-cut 
technique has a higher risk of PEP than conventional cannulation has long been debated. Some studies report 
that pre-cut sphincterotomy is associated with a 10%-20% increase in the risk of acute pancreatitis and is, 
therefore, a dangerous procedure [Suissa et al. 2005, Masci et al. 2001].  However, there are studies reporting 
equivalent rates of PEP in patients undergoing pre-cut and conventional cannulation [Freeman et al. 2001, 
Vandervoort et al. 2002]. Prolonged cannulation attempts using standard cannulation techniques before a pre-
cut probably represent a more significant risk factor for PEP than the pre-cut itself [de Weerth et al. 2006, 
Parlak et al. 2007]. Nevertheless, a prospective randomized controlled trial in Toronto [Tang et al. 2005] 
suggested that needle-knife papillotomy after 12 minutes of cannulation attempts is not safer than persistence 
in the standard cannulation strategy and that both approaches are equally effective in terms of cannulation 
success (>99%). A meta-analysis of six prospective randomized studies has shown that early application of 
pre-cut has about the same cannulation frequency as prolonged cannulation attempts, but that early 
conversion to pre-cut sphincterotomy reduces the risk of PEP, although it does not reduce the overall risk of 
other procedure-related complications [Cennamo et al. 2010]. Pre-cutting with a needle-knife requires 
substantial endoscopic therapeutic experience and is one of the predictive factors of ERCP-related 
complications [Shakoor et al. 1992]. Furthermore, performing a pre-cut should be considered only when there 
is a strong indication for bile duct cannulation (EG: III, RG: B) [Cotton 2010]. 
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Pre-cut with an Erlangen papillotome is an 
unusual alternative method, figure 8. The 
instrument resembles a sphincterotome but 
there is no tip in front of the cautery wire. 
The two small single-center case series that 
are available report excellent cannulation 
success (98%) and complication rates (8.3%) 
for the Erlangen papillotome; these are 
equivalent to needle-knife cannulation 
[Binmoeller et al. 1996, Palm et al. 2007]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pancreatic duct assisted cannulation techniques 
 
There are different two-step procedures for 
obtaining biliary cannulation by taking 
advantage of the situation in which 
cannulation persistently enters the pancreatic 
duct unintentionally. One of these is the 
pancreatic guidewire-assisted or double-wire 
technique, figure 9, and the other is trans-
pancreatic sphincterotomy, figures 10 and 
11. 
Pancreatic guidewire-assisted or double-
wire technique: Few data are available 
concerning the success and PEP rates for 
these techniques, and the existing data are 
inconsistent. In four small case series, the 
success rate for biliary cannulation ranged 
from 47%-83%, and the rate of PEP ranged 
from 2%-12% [Draganov et al. 2005, Ito et 
al. 2008, Grönroos et al. 2011]. In another 
trial containing 97 patients in the double-
wire group, de Tejada et al. [Herreros de 
Tejada et al. 2009] concluded that the 
success rate was not significantly different 
between the two methods (double-wire 47% 
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versus standard cannulation 56%) but the percentage of PEP was slightly higher in the double-wire group 
(17% versus 8%). The discrepancy in results probably reflects the different settings of the studies, with the 
results favoring the double-wire technique coming from high-volume centres. Nevertheless, the cannulation 
method itself may be appropriate to try, and if it is not successful, it can always serve as a first step in a trans-
pancreatic sphincterotomy.  
 
Some experts advocate the placement of a pancreatic stent before removing the guidewire from the pancreatic 
duct as a protective measure for avoiding PEP. Pancreatic stent can also be used as a guide for biliary 
cannulation in combination with or without needle-knife sphincterotomy [Slivka 1996]. Small case series 
report an overall cannulation success rate close to 90% and a PEP rate around 5% to 20% [Goldberg et al. 
2005, Fogel et al. 1998]. 
 
Trans-pancreatic sphincterotomy: Data from case series show a successful cannulation rate of 85% after 
initial trans-pancreatic sphincterotomy and a successful cannulation rate greater than 95% after an additional 
needle-knife incision [Weber et al. 2008, Halttunen et al. 2009]. 
 
 
It might be assumed that the risk of causing PEP would be increased by these procedures. However, in 
comparative studies between trans-pancreatic sphincterotomy and conventional pre-cut technique, it appears 
that the risk of PEP is comparable [Kahaleh et al. 2004, Halttunen et al. 2009]. The rational for using a 
prophylactic pancreatic stent would appear to be closest to redundant after the sphincter has disrupted the 
outlet resistance. The lifetime risk for a young individual undergoing pancreatic sphincterotomy remains 
unknown. The risk of developing papillary stenosis is currently unclear, and whether it is of any significant 
clinical importance remains to be seen in future follow-up studies [Udd et al. 2010]. 
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1.3.11  Combined endoscopic treatment of common bile duct stones  
 
Various invasive or surgical approaches are available for entering the supra-papillary portion of the biliary 
system by insertion of an antegrade guidewire that crosses the papilla of Vater. When the tip of the guidewire 
is positioned in the duodenum, a so-called rendezvous cannulation can take place in order to get an instant 
biliary access, figures 12 and 13. Figures 14-17 describes alternative two-step solutions for RV-ERCP. 
 
Combined laparoendoscopic ERCP with rendezvous cannulation (RV-ERCP) 
 
 
 
The first case report concerning laparoendoscopic ERCP with rendezvous was presented by Deslandres et al. 
in 1992 at an international meeting [Gagner 1992]. Later a case series of four patients was published in 1993 
[Deslandres et al. 1993]. The procedure used can more accurately be described as a needle-knife pre-cut 
sphincterotomy supported by a biliary-placed catheter in the papilla that was introduced trans-cystically by 
the surgeon. In 1992-1994 Mayrhofer et al. [Mayrhofer et al. 1992] and Feretis et al. [Feretis et al. 1994] 
independently described a technique in which the surgeon inserted a sphincterotome, rather than a catheter, 
through the cystic duct and performed a sphincterotomy under simultaneous endoscopic surveillance by a 
duodenoscope. In 1996, Nakajima et al. [Nakajima et al. 1996] presented a case in which they carried out the 
rendezvous procedure by using a front-viewing endoscope and snared the transcystic-placed guidewire with a 
basket catheter and pulled the guidewire, together with the endoscope, back to the mouth. The duodenoscope 
was then introduced the entire way down to the duodenum with the guidewire stretched gently at both ends, 
and cannulation was completed with the sphincterotome running along the transcystic guidewire. Judging by 
the description, this was probably the first complete laparoendoscopic guidewire-assisted rendezvous 
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procedure. In 1997, Huntington et al. [Huntington and Bohlman 1979] presented a case series of 14 patients 
who underwent two-step laparoendoscopic rendezvous with a transcystic guidewire that was left in situ with 
the distal end curled in the duodenum. However, after the first five cases, they had to change the method 
because the guidewire had escaped out of reach when ERCP was done the next day. Instead, they successfully 
employed the Nakajima approach. However, this somewhat cumbersome two-step method did not gain any 
immediate interest. At the end of the millennium, rendezvous technique was still evolving, and Miscusi et al. 
[Miscusi et al. 1997] and Cavina et al. [Cavina et al. 1998] presented small case series of different ways of 
performing rendezvous-like procedures by using retrieving baskets or inserting a sphincterotome through the 
cystic duct and assisting the cannulation by opening the papilla by opening the basket or by capturing the 
sphincterotome and pulling it into the bile duct. Notably, the study by Cavina et al. [Cavina et al. 1998] 
seems to present a single case of guidewire-assisted rendezvous as we know it today. At the same time, 
interest was expressed in implementing peroperative ERCP without using rendezvous techniques. A plurality 
of case series [Basso et al. 1999, Cemachovic et al. 2000, Kalimi et al. 2000, Meyer et al. 2002, Williams and 
Vellacot 2002, Wright et al. 2002] and a recent randomized trial [Elgeidie et al. 2011] showed that 
peroperative ERCP without rendezvous assistance could be as effective and safe as conventional pre- or post-
operative ERCP, in terms of stone clearance and ERCP-associated complications. However, an important and 
unanimous conclusion of these studies was that single-stage management of CBDS offers a stricter indication 
for ERCP, provided peroperative cholangiography is done at the same time, which in turn minimizes the risk 
of unnecessary (negative) ERCP investigations. Moreover, if endoscopic treatment fails, the surgeon may 
take immediate action to convert the procedure for surgical treatment options.  
 
Another controversy was whether common bile duct stones detected at the time of laparoscopic 
cholecystectomy should be managed by laparoscopic technique or with peroperative ERCP. A comparative 
study by Wei et al [Wei et al 2003], two randomized trials by Hong et al [Hong et al 2006], and two studies 
by ElGeidie et al [ElGeidie et al 2011a, 2011b] could not find any overall statistically significant differences 
between laparoscopic stone extraction and non-rendezvous ERCP treatment in terms of success rate (88% to 
92% versus 89% to 97.2%) or post-operative complications (5% to 12% versus 7% to 9.3%).  
 
An extension of the previous issue was whether peroperative ERCP performed with rendezvous and assisted 
by the transcystic approach was an improvement over standard ERCP techniques. Five Italian case series 
[Tatulli et al. 2000, Filauro et al. 2000, Iodice et al. 2001, Saccomani et al. 2005, Borzellino et al. 2010], one 
Swedish study [Enochsson et al. 2004], and one Egyptian [Ghazal et al. 2009] case series included a total of 
345 patients with CBDS treated with laparoendoscopic techniques with consistent use of guidewire-assisted 
rendezvous. The overall stone clearance rates ranged from 86% to 98% with mean and median values close to 
94%. Furthermore, compared with the expected situation, PEP was markedly absent. The latter observation 
became a target issue in two RCT between preoperative ERCP and RV-ERCP. A study by Rabago et al. 
[Rábago et al. 2006] and another by Lella et al. [Lella et al. 2006] suggested that preoperative ERCP 
followed by LC was equally effective as RV-ERCP in terms of stone clearance but that PEP was significantly 
lower in the RV-ERCP group. A comparative study by La Greca et al. [La Greca et al. 2007] found that 
pathological high levels of pancreatic amylase, which are indications of iatrogenic pancreatic injury, were 
significantly greater in patients who were treated with conventional ERCP than in patients undergoing 
laparoendoscopic rendezvous ERCP.  
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1.3.12 Alternative methods for obtaining biliary access 
 
Failure to achieve deep biliary cannulation occurs in less than 10% of patients [Enochsson et al. 2010]. 
Alternative management includes a percutaneous approach by PTC or a transmural approach by means of 
EUS. 
 
Percutaneous transhepatic cholangiography (PTC) 
 
Percutaneous transhepatic cholangiography was originally a radiologic imaging technique for the purpose of 
visualizing biliary anatomy and pathology [Carter and Saypol 1952]. PTC requires the insertion of a needle 
through the abdominal wall and into the liver to reach an intrahepatic bile duct. PTC is no longer used for 
routine diagnostic purposes, but it may used as an alternative option when ERCP or surgery is not feasible 
[Ozcan et al. 2012]. With PTC technique, CBDS can be removed [Dotter et al. 1979] and fragmented 
[Burhenne et al. 1989]. A percutaneous transhepatic choledochoscope can provide support and improve the 
therapeutic results. Reported success rates for extra-hepatic stones are over 95% [Ozcan et al. 2012]; success 
rates for intrahepatic stones are somewhat lower, ranging between 60% and 90% [Cheon et al. 2009]. 
However, it is generally accepted that percutaneous biliary procedures have higher complication rates than 
ERCP; these include cholangitis, subphrenic abscess, bleeding, haemobilia and intra-abdominal bile leakage 
[Sirinek and Levine 1989]. PTC was used in the original method of a rendezvous cannulation that was 
described in the mid 1980’s [Long et al. 1984, Shorvon et al. 1985, Scapa et al. 1994] and was quite similar 
to the RV-ERCP that Nakajima et al. described [Nakajima et al. 1996] (see 1.3.11). 
 
Endoscopic ultrasonography guided rendezvous (EUS RV) 
 
With the recent advent of linear-array echo endoscopes, EUS has emerged as a salvage procedure for failed 
biliary cannulation. Dilatated intrahepatic bile ducts can be needle-punctured under EUS guidance from the 
stomach into the liver (hepaticogastrostomy) [Burmester et al. 2003] and extra-hepatic ducts can reached 
through supra-papillary puncture of the duodenum (choledochoduodenostomy) [Artifon et al. 2007] followed 
by cholangiography and antegrade insertion of a guidewire into the CBD and transpapillary advancement. 
Although the literature is sparse, the available data concerning choledochoduodenostomy appear promising, 
with a cannulation success rate exceeding 90% and a procedural complication rate around 3% to 4%, which 
seems to be on par with pre-cut sphincterotomy [Dhir et al. 2012]. However, hepaticogastrostomy seems to 
have a considerately higher rate of complications (20%) [Artifon et al. 2012].  
 
 
1.3.13 Endoscopic extraction of common bile duct stones 
 
Balloon and basket 
 
With an adequate endoscopic sphincterotomy, sometimes combined with papillary balloon dilatation, stones 
measuring up to 15 mm can be removed with retrieval balloons or baskets, and it is suggested that more than 
80% of all common bile duct stones should be managed when these standard procedures are used (EG: IV, 
RG: C) [Bergman et al. 1997]. Stones that cannot be extracted using this first-line treatment are referred to as 
difficult common bile duct stones. 
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Dilatation-assisted stone extraction (DASE) 
 
In the cases in which standard techniques fail due to 
large stone diameter, endoscopic papillary large 
balloon dilatation following sphincterotomy could 
be an appropriate second-line alternative for 
difficult stones, figure 18.  Previous prospective 
studies [Maydeo and Bhadari 2007, Ersoz et al. 
2003] have reported successful and safe removal in 
approximately 95% of the cases when using an 
esophageal/pyloric balloon ranging from 15 mm to 
20 mm. Complications, mostly transient bleeding, 
occurred in 15%. The risk for developing PEP 
seems to be surprisingly low, considering the 
similarity with EPBD technique. The DASE 
technique, however, is preceded by sphincterotomy; 
therefore mechanical compression is less towards 
the pancreatic duct [Attam and Freeman 2009]. 
However, experience is still limited in this area. 
There are concerns about whether this technique is 
applicable to young patients, and the dilatation limit 
for patients with a slender bile duct has not yet been 
determined [Attasaranya and Sherman 2007].  
 
 
 
 
 
 
Mechanical lithotripsy 
 
Mechanical lithotripsy involves the use of a lithotriptor that fragments the stone by sheer compressing or 
crushing force against the metal sheet of the lithotripsy device after the stone has been captured within a wire 
basket. Bile duct clearance using a mechanical lithotriptor is successful 80% to 90% of the time, even when 
stones from 15 mm to 35 mm in size are included in the analysis. Complications are seen in about 10% of 
cases [Cipolletta et al. 1997].  
 
Intraductal endoscopy with electrohydraulic lithotripsy (EHL) or laser lithotripsy (LL) 
  
As a third-line treatment for difficult stones, for use when the previously-mentioned methods have failed or 
are not feasible, electrohydraulic lithotripsy (EHL) or laser lithotripsy (LL) can be applied as an alternative, 
figure 19. Although EHL and LL do not share the same physical principles, both methods lead to electrical 
energy that, when discharged in liquide, forms an explosive plasma channel or bubble by vaporization, which 
in turn will cause a high-energy shock wave that is delivered as brief pulses that will finally shatter the stone 
into pieces [Binmoeller et al. 1993]. Both EHL and LL have about the same efficacy, with fragmentation 
rates >95% and stone clearance rates ranging from 80% to 90%, and minimum numbers of adverse events 
[Jakobs et al. 1997, Arya et al. 2004] (EG: III, RG: B).  
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1.3.14 Permanent endoprothesis of common bile duct stones 
 
Biliary stenting has been suggested as an alternative to curative therapy in elderly or frail patients who are 
unlikely to tolerate surgery or prolonged endoscopic procedures [Bergman et al. 1995, De Palma et al. 2000]. 
In addition, some authors support long-term stenting (3 to 6 months) because there are numerous examples 
showing that 60% of stones can eventually decrease in size, split into pieces, or even disappear under the 
influence of an indwelling plastic endoprothesis, preferably multiple pigtail ones [Horiuchi et al. 2010, Lee et 
al. 2011]. Nevertheless, the greatest draw-back to long-term indwelling stenting is the increased risk of 
recurrent cholangitis and mortality, especially for patients with a gallbladder in situ [Chopra et al. 1996, Hui 
et al. 2003, Pisello et al. 2008]. In view of the long-term risk of biliary-associated morbidity and death, bile 
duct clearance should always be prioritized as first-line treatment if possible (EG: Ib, RG: A). 
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1.3.15 Alternatives to surgical and endoscopic treatment 
 
Extracorporeal shockwave lithotripsy (ESWL) 
 
ESWL can be a safe and effective alternative for the treatment of difficult common bile duct or cystic duct 
(Mirizzi) stones in patients who are at high risk for surgery and in whom all conventional methods, including 
EHL and LL, have failed [Lindström et al. 1992]. Bile duct stone clearance following ESWL ranges from 
80%-90%. However, the procedure is rather difficult and time-consuming to perform. Most patients will 
require ERCP with nasobiliary tube placement prior to the first ESWL session to enable stone identification. 
Following the ESWL session, a second ERCP is performed to remove the CBDS and/or fragments. In 
general, ESWL has to be repeated and followed by subsequent ERCP.  
 
Dissolution agents 
 
During the late 1970s and early 1980s, alternatives to cholecystectomy for the treatment of biliary stone 
disease became available. Pharmacological dissolution of common bile duct stones by different solubilizing 
agents such as mono-octanoin, methyl tert-butyl ether (MTBE) [Diaz et al. 1992] and EDTA/bile acid 
solution, administered with an ERCP-installed nasobiliary tube, has been proposed. Unfortunately, the overall 
efficacy of these agents is disappointingly low.  In addition, they have serious side-effects and are, therefore, 
not recommended under any circumstances in clinical practice (EG: III, RG: B).  
 
Bile acid dissolution therapy with chenodeoxycholic [Schoenfield and Lachin 1981] and ursodeoxycholic 
acid [Bachrach and Hofmann 1982] has been tested together with extracorporal lithotripsy methods (ESWL) 
for use against gallstones (cholesterol stones). However, interest waned when it became apparent that 
recurrence of symptomatic biliary stones was seen in over 50% of the patients [Lanzini and Northfield 1994]. 
 
1.3.16 ERCP-associated complications 
 
Acute pancreatitis or post-ERCP pancreatitis (PEP) 
 
Acute pancreatitis is the most frequent and important complication associated with ERCP and has an 
approximate incidence around 3.5% among unselected patients [Andriulli et al. 2007b, Enochsson et al. 
2010]. In 90% of cases, the disease occurs as a mild (45%) to moderate (46%) inflammation that is harmless 
in its nature when it is limited to the pancreatic gland. Usually the patient recovers within days after treatment 
with conservative measures. In case of severe PEP, a serious and seemingly uncontrolled inflammation 
develops that, in a worst case scenario, can lead to systemic inflammatory response syndrome (SIRS) and 
necrosis of pancreatic tissue with severe consequences in the form of secondary infection, abscess 
development, sepsis and multiple organ dysfunctional syndrome (MODS). The overall reported mortality rate 
for unselected patients with pancreatitis is around 3% (CI, 1.65% - 4.51%) and patients diagnosed with severe 
necrotizing pancreatitis have a mortality rate around 40% to 60%, despite intensive care treatment [McKay et 
al. 1999]. 
  
Definition of post-ERCP pancreatitis: The consensus definition of PEP and the classification of severity were 
proposed by Cotton et al. [Cotton et al. 1991]: a clinical pancreatitis with amylase at least three times normal 
more than 24 hours after the procedure that requires hospital admission or prolongation of planned admission. 
There are, however, some variations across studies in the definition of clinical pancreatitis, such as new or 
worsened abdominal pain that take into account patients having a temporary outburst of already-established 
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pancreatitis [Freeman et al. 1996]. There are also examples of authors who have different pathological 
thresholds for amylase - two-fold [Acosta et al. 2006] or even five-fold [Lella et al. 2006] increased values. 
However, high levels of amylase (hyperamylasemia) are also frequently observed shortly after ERCP without 
concomitant clinical signs of pancreatitis, and sometimes the opposite is observed [Testoni and Bagnolo 
2001, Bretthauer et al. 2007]. The grading system for severity proposed by Cotton et al. [Cotton et al. 1991] 
is based mainly on the length of hospitalization: mild is less than three days, moderate is more than four and 
shorter than ten days and severe is more than ten days or hemorrhagic pancreatitis, phlegmon, pseudocysts or 
the need for interventional procedures. 
 
The mechanism responsible for PEP is not fully known. A number of large prospective multicenter studies 
[Loperfido et al. 1998, Williams et al. 2007] and a large meta-analysis [Masci et al. 2003] suggest that there 
are a number of procedure-related and patient-related causes that should be considered as independent risk 
factors. The independent risk factors used in multivariate analysis may also have a cumulative effect when 
they are combined [Freeman et al. 2001, Cheng et al. 2006].  
 
Procedure-related risk factors:  A number of events have been associated with PEP, including biliary balloon 
dilatation, a high number of cannulation attempts, ampullectomy, and mechanical damage to the papilla and 
pancreatic sphincter by, for example, pre-cut sphincterotomy with resulting development of papillary edema. 
Contrast medium in the main pancreatic duct causing intracellular disrupture of acinar cells due to high 
hydrostatic injection pressure is also a well-known cause.  
 
High-risk patients: Certain categories of patients seem to be at greater risk than others. Suspected sphincter of 
Oddi dysfunction (SOD) is probably the strongest solitary risk factor, with an incidence of post-ERCP 
pancreatitis between 10% to 30%. Female gender, a previous history of acute pancreatitis, young age, is also 
categories associated with a higher risk. Chronic pancreatitis appears to decrease the risk. 
 
Hemorrhage 
  
Bleeding is a relatively common complication of sphincterotomy, with an overall frequency of 0.8 % to 3.2% 
[Masci et al. 2001] depending on the definition. Severe bleeding has been reported in 0.3% to 0.5% of 
sphincterotomy cases [Freeman et al. 1996, Christensen et al. 2004]. The vast majority of all episodes of 
haemorrhage usually ceases without treatment or managed successfully within minutes by standard 
haemostatic endoscopic procedures. As a last resort, severe bleeding can be managed either by angiographic 
or surgical methods.  
 
Perforation  
 
Perforations caused by sphincterotomy are rare and occur in about less than 1% of all procedures.  They are 
usually retro-duodenal and are therefore classified anatomically as retroperitoneal perforations. Intraperitoneal 
perforations are very rare, but are more severe. Generally speaking, intraabdominal perforations can be 
extremely dangerous for the patient if not treated in time, and fatality rates of 8% to 14% have been reported 
[Freeman et al. 1996, Christensen et al. 2004]. A majority of perforations are small and appear to be able to 
be managed by conservative treatment. However, the recommendations in the literature vary widely from 
conservative treatment to early open operation, endoscopic intraductal drainage with a biliary stent, or 
nasobiliary tube placement, depending on the clinical course. Since delayed recognition is associated with 
poor outcomes, the challenge is to identify the perforation early in the course of the event and select those 
patients who will not respond on conservative treatment. 
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Prevention of post-ERCP pancreatitis (PEP) 
 
Endoscopic pancreatic duct stent: Prophylactic pancreatic stenting is recommended to prevent post-ERCP 
pancreatitis in conditions that are considered high-risk cases [Choudhary et al. 2011, Kawaguchi et al. 2012], 
including SOD [Smithline et al. 1993, Tarnasky et al. 1998], difficult cannulation [Fazel et al. 2003], 
endoscopic papillectomy [Harewood et al. 2005], and papillary balloon dilatation [Aizawa and Ueno 2001], 
(EG: Ib, RG: A). Prophylactic pancreatic stents are designed to overcome temporary ERCP-related papillary 
oedema. After their function has been performed, more than 95% will dislodge spontaneously within days 
after the procedure, mitigating the need for a second-look endoscopy. There seems to be no doubt about the 
efficacy of prophylactic pancreatic stents in high-risk patients [Andriulli et al. 2007a, Singh et al. 2004]. On 
the other hand, there are controversies concerning whether stenting should be performed in patients with an 
average risk of developing PEP, especially since the incidence of PEP has been reported to be as high as 65% 
among patients in whom cannulation of the pancreatic duct has failed [Freeman et al. 2004]. However, a 
recent prospective multicenter randomized trial that included 37 high-volume centres in Japan, which 
compared prophylactic pancreatic stent placement versus non-stent placement in an unselected patient cohort 
regardless of risk factors, found post-ERCP pancreatitis in 7.9% of the prophylactic stent group and 15.2% of 
the non-prophylactic stent group [Sofuni et al. 2011]. The success rate of pancreatic stent placement was 
88.3%. However, the difference between groups was not statistically significant in the intention-to-treat 
analysis, probably due to a relatively small sample size.  
 
Pharmacological prevention of post-ERCP pancreatitis 
 
A number of forms of pharmacological agents have been suggested over the years to prevent PEP. However, 
available data are conflicting. There are examples where the early data was promising but was then tempered 
by larger, more carefully-designed studies that failed to find a statistically-significant benefit for the drug in 
question. Agents that have been shown to be ineffective include pharmacological drugs that reduce the 
pressure of the sphincter of Oddi such as glyceryl trinitrate (nitroglycerin) [Shao et al. 2010], botulinum toxin 
[Gorelick et al. 2004], epinephrine [Matsushita et al 2009], lidocaine [Prat et al 2002], and nifedipine [Sand 
and Nordback  1993], or antioxidant agents such as allopurinol [Andriulli and Annese 2008], N-acetylcystein 
[Katsinelos et al. 2005] and ß-Carotene [Lavy et al. 2004]) or anti-inflammatory agents such as 
glucocorticoids [Bai et al. 2008], heparin [Li et al. 2012], interleukin-10 [Sherman 2009b], pentoxifylline 
[Kapetanos et al. 2007], or semapimod [van Westerloo et al. 2008]), or recombinant platelet-activating factor 
acetylhydrolase [Sherman et al. 2009a], or antibiotics [Brand et al. 2010]. Prophylaxis with antisecretory 
drugs (e.g. somatostatin analogues) and antiprotease drugs (e.g. gabexate, ulinastatin, nafamostat mesylate) 
showed some benefit in smaller trials, but they were found to be ineffective in patients with an average and 
high risk for post-ERCP pancreatitis when they were evaluated in a large meta-analysis [Andriulli et al. 2002, 
Seta and Noguchi 2011].  
 
According to the European Society of Gastrointestinal Endoscopy (ESGE), the only prophylactic drug that 
could be recommended in clinical practice for limiting the development of PEP are non-steroidal anti 
inflammatory drugs (NSAIDs) given as a single dose (diclofenac 100 mg) administered rectally (EG: Ia, RG: 
A) [Dumonceau et al. 2010]. However, similar studies with NSAIDs administered intramuscularly [Senol et 
al. 2009] or intravenously [Bhatia et al. 2011] have not shown any reduction of post-ERCP pancreatitis. So 
far, no pharmacological drug has been universally recommended in the purpose to reduce the incidence of 
post-ERCP pancreatitis.  
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2 AIMS 
 
The aims of the studies in the present thesis were as follows: 
 
Paper I Primary: To evaluate the efficacy of RV-ERCP in a routine clinical setting.  
 Secondary: To study whether the method is safe in terms of complications associated with 
ERCP and to determine whether the prolonged operation time compared  
with conventional LC influences the hospital stay.  
 
Paper II Primary: To evaluate 10 years of clinical experience with peroral intraductal 
mother-baby endoscope assisted lithotripsy with EHL or LL treatment of 
difficult CBDS, focusing on the success rate of stone clearance. 
 Secondary: To evaluate the long-term clinical outcome concerning stone 
  recurrence, cholangitis and biliary associated pain.  
 
Paper III To examine whether the use of RV-ERCP could prevent post-ERCP pancreatic damage 
 compared with conventional ERCP cannulation in patients 
  treated for CBDS.   
 
Paper IV Primary: To investigate the relation between cannulation techniques (RV-ERCP 
  versus conventional ERCP) and the risk of developing PEP.  
 Secondary: To identify risk factors other than cannulation technique associated 
   with PEP after ERCP on non-sphincterotomized papillas. 
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3 PATIENTS AND METHODS 
 
3.1 PAPER I 
Design and data collection 
All data were collected and analyzed retrospectively from medical charts and included patients demographics, 
operative and radiographic findings, the success rate of stone clearance, procedural time, per- and 
postoperative complications, and the length of hospital stay. The study period covered two years (January 
2000 to December 2001) of cholecystectomies at the Karolinska University Hospital Huddinge. The 
department uses IOC policy on a routine basis. Out of all cholecystectomies, we identified all patients treated 
with RV-ERCP as a result of IOC findings of CBDS and compared this group with the large cohort of 
cholecystectomies. 
 
Surgical procedure 
LC was conducted with the four trocar technique ad modum Olsen [Olsen 1991] together with peroperative 
cholangiography through a small incision in the cystic duct (cysticotomy). When the cholangiogram 
suggested a common bile duct stone, the endoscopy team was alerted.  After the endoscopist had positioned 
the duodenoscope en face in front of the papilla, an RV-ERCP with sphincterotomy was conducted according 
to previous description. See figures 12 and 13. If stone clearance was incomplete, an indwelling plastic 
biliary stent was placed as a bridge to final postoperative endoscopic treatment. After the RV-ERCP was 
terminated, the LC could proceed accordingly to the standard protocol.  
 
Logistic protocol 
A basic logistical chart was created for using RV-ERCP during office hours. Among other things, there were 
instructions for the operating staff about arranging the endoscopic equipment, X-ray apparatus and anaesthetic 
machine in the operating theatre during the waiting time for the endoscopy team to arrive. In addition, a 
trolley was purchased to transport the necessary endoscopic equipment and the duodenoscope.  
 
Statistical analyses 
Baseline characteristics and comparative data were calculated and quantitative data was presented as mean 
values, median values and standard deviations. The level of significance (α-value) was 5% (p= 0.05).  
 
3.2  PAPER II 
Design and data collection 
In this retrospective study, all data was collected through medical charts from all identified patients who were 
treated consecutively for difficult CBDS with mother-baby scope-assisted lithotripsy at two different Swedish 
surgical units, the Karolinska University Hospital and Östersunds County Hospital, during the period from 
December 1995 to September 2006. In the cohort, we analyzed data concerning the following: patient 
demographics, preoperative clinical features, previous treatments, per procedural endoscopic and radiographic 
characteristics of stones, success rates of stone fragmentation and ductal stone clearance, procedural times, 
per- and postoperative complications, length of hospital stay, and long-term follow-up. Information 
concerning long-term follow-up data was collected from medical charts or by contacting patients directly by 
telephone at the time of the follow-up evaluation. 
 
 
 
 
40 
Surgical procedure 
Lithotripsy within the CBD was performed under direct optic surveillance by two endoscopists, with one 
endoscopist monitoring a per oral cholangio-endoscope (baby-scope) that in turn was supported by a second 
endoscopist who positioned the baby-scope through the instrumental channel of a duodenoscope (mother-
scope). The lithotriptor was advanced through the instrumental channel of the baby-scope. The fragmentation 
was conducted either by EHL, using a 1.9 Fr coaxial electrode probe or by pulsed dye LL, using a 200 µm 
fine-caliber laser fiber at a wavelength of 504 nm. All procedures were performed under general anesthesia 
with the patient in the supine position. Intravenously-administered antibiotics were used prophylactically in 
all patients. If complete stone clearance was not accomplished, an indwelling plastic biliary stent was placed 
as a bridge to the next treatment session.  
 
Statistical analyses 
All patients referred for intraductal treatment for difficult CBDS were analyzed as an intention to treat. 
Baseline characteristics and descriptive data were calculated and data were presented as mean values, median 
values, and ranges. 
 
3.3 PAPER III 
Design and data collection 
A prospective comparative controlled trial on patients undergoing ERCP in two different endoscopic 
treatment settings due to CBDS. Preoperative screening data was recorded concerning the following: physical 
examination, baseline laboratory values, radiographic imaging (ultrasound, CT-scan or MRCP) in order to 
confirm the presence of CBDS and to rule out ongoing pancreatitis and/or cholecystitis, which in turn could 
influence the results.  
 
Three study groups were identified. Regardless of the suspicion of CBDS, every patient with 
cholecystolithiasis who was fit for general surgery was prepared for a standard LC. According to the results of 
the IOC, patients were allocated to one of two groups: RV-ERCP (if IOC was positive for CBDS) or LC 
alone (if IOC turned out to be negative). The latter group became a control group. The conventional ERCP 
group consisted of previously cholecystectomised patients with a high suspicion of choledocholithiasis.  
The endoscopist documented all data according to the protocol immediately after the procedure. All patients 
were hospitalized for a minimum of 24 hours and had a clinical examination and collection of blood samples 
at 4 hours, 8 hours and 24 hours postoperatively. All postoperative clinical examinations and the 30-day 
follow-up interview were performed by a nurse assigned to the study. 
The primary objective was to compare the incidence of pancreatic injury estimated as leakage of pancreatic 
enzymes in the cohorts assigned to the different treatment groups. Secondary objectives were to study the rate 
of PEP, successful cannulation, and CBDS clearance. 
 
3.3.1 Surgical procedures 
Laparoscopic cholecystectomy (LC) 
LC was performed using standard laparoscopic technique ad modum Olsen, [Olsen, 1991] with 
pneumoperitoneum, introduction of four troachars, and isolation of the cystic duct. All procedures included 
peroperative cholangiography through a small incision in the cystic duct, in order to exclude CBDS and to 
delineate the bile duct anatomy. 
 
Combined laparoendoscopic ERCP with rendezvous- assisted cannulation (RV-ERCP) 
Performed according to the previous description, see figures 12 and 13. 
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Conventional ERCP 
All patients were investigated under general anesthesia, and ERCP was performed by experienced 
endoscopists, using conventional duodenoscope and biliary retrograde cannulation by wireguided cannulation 
(WGC) through a sphincterotome, see figures 2 and 3.  If cannulation failed, pre-cut techniques was used, 
see figure 6. After sphincterotomy, stone extraction was carried out with retrieval balloons or baskets. If stone 
clearance was incomplete, a biliary endoprothesis was inserted. 
 
Laboratory analysis 
Blood samples were collected in ice-cold EDTA (ethylenediaminetetraaceticacid) tubes within 30 minutes; 
plasma was obtained after centrifugation and stored at -70°C until further analysis. Procarboxypeptidase B 
and trypsinogen-2 was determined in plasma by use of in-house double-antibody enzyme-linked 
immunosorbent assays (ELISA) developed at the Department of Surgery, Clinical Sciences, Malmö Skåne 
University Hospital. Pancreatic amylase and C-reactive protein (CRP) were collected in venous blood and 
analyzed consecutively at the Department of Clinical Chemistry at the Karolinska University Hospital in 
Huddinge. All samples were coded at analysis.  
 
 
3.3.2 Statistical analyses 
 
Sample size estimation 
We made a sample size calculation based on following assumptions: significance level of alpha=0.05, power 
of 75% (beta=0.25), and a reduction of the outcome pancreatic enzyme leakage from 14% in the conventional 
ERCP group to 1% in the RV-ERCP group.  This estimation was based on previous studies of proCAPB and 
post-ERCP pancreatitis [Petersson et al. 2002].  
 
Statistical Analysis 
Pancreatic amylase, proCAPB and trypsinogen-2 were analyzed using a mixed linear model with one 
between-group factor, i.e. conventional ERCP, rendezvous ERCP and control group, and one within-group 
factor, which was time (0, 4 hours, 8 hours and 24 hours), and the subsequent interaction between the factors. 
In the case of significant interactions (p-values less than 0.05), simple main effect tests were performed, i.e. 
effects of one factor holding the level of the other factor fixed.  
Results were presented as mean, SD, and 95% confidence intervals. The variables with positively skewed 
distributions (e.g. proCAPB, trypsinogen-2, pancreatic amylase) were log-transformed before the formal 
analyses. The binomial responses were subsequently analysed by fitting a generalized estimating equations 
model with the Genmod procedure. These latter parameters were presented as odds ratios (OR) and 95 % CI. 
P values less than 0.05 were considered statistically significant. 
 
In order to investigate the strength of correlation between 8-hour results for enzyme leakage (pancreatic 
amylase and proCAPB) and possible associative variables; The Spearman Rank Order Correlation was used 
for analysis of age, procedure time, number of cannulation attempts, pancreatic duct cannulation, and contrast 
injection variable. The Mann-Whitney U Test was used to analyse gender, use of a precut technique. The 
Kruskal-Wallis ANOVA by Ranks Test was used for ASA-classification. 
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3.3.3 Definition of outcome measures 
 
Post-ERCP pancreatitis (PEP) 
PEP was defined according to the 1991 Consensus Guidelines [Cotton et al. 1991] as a post-procedural onset 
of upper abdominal pain persisting for at least 24 hours combined with an increase in serum pancreatic 
amylase equivalent to at least three times the upper limit of normal. The severity of PEP was graded 
according to the same guidelines. 
 
Pancreatic Amylase 
Measurement of pancreatic amylase is generally used in clinical practice to support the diagnosis of acute 
pancreatitis and was used in this study as a surrogate marker for pancreatic injury caused by ERCP 
intervention.  Hyperamylasemia was defined as amylase levels more than three times the upper limit of 
normal 4 to 24 hours after ERCP.  
 
Procarboxypeptidase B (proCAPB) 
Procarboxypeptidase B (proCAPB) is by definition an inactive proenzyme to the activated carboxypeptidase 
B (aCAP) and is one of the major digestive proteolytic enzymes synthesized in the pancreatic acinary cells.  
Under normal physiological conditions, it is activated in the duodenum by trypsin, in company with other 
proteolytic, amylolytic, and lipolytic enzymes [Geokas et al. 1975]. ProCAPB is a large (45 kDa) stable 
protein and, in normal conditions, is found in low concentrations in both serum and urine [Müller et al. 2003]. 
Therefore, proCAP was used in the current study as a surrogate variable for injury of the pancreatic gland. 
 
Trypsinogen-2, Human anodal trypsinogen (HAT) 
Trypsinogen is an inactive precursor of trypsin, which is the key enzyme for activation of all proteolytic 
enzymes in the duodenum and also an important protagonist in the early stage of acute pancreatitis. 
Trypsinogen appears in two major forms in pancreatic juice: trypsinogen-1 (cathodal trypsinogen) and 
trypsinogen-2 (anodal trypsinogen) [Kimland et al. 1989]. Elevated levels of both trypsinogen 1 and 2 are 
associated with acute pancreatitis and represent intracellular leakage from disruptured acinar cells in the 
pancreas [Regnér et al. 2008]. In the current study, trypsinogen-2 was used as a surrogate variable for 
pancreatic injury. 
 
Difficult cannulation 
Difficult cannulation was defined as more than six cannulation attempts for deep biliary cannulation or the 
need for pre-cut techniques.  
 
 
3.4 PAPER IV 
3.4.1 Design 
A nationwide population-based nested case-control study was conducted within the cohort of ERCP 
procedures in Sweden, all recorded in a nationwide quality registry during a period of three years, 2007 - 
2009.  
 
3.4.2 The source of data; GallRiks 
The data were collected from the Swedish Registry for Gallstone Surgery and ERCP (GallRiks), a nationwide 
quality registry. GallRiks has been collecting data since it was established in 2005 under the direction of the 
Swedish National Board of Health and Welfare (Socialstyrelsen) and the Swedish Surgical Society (Svensk 
 43 
Kirurgisk Förening, Svensk Förening för Övre Abdominell Kirurgi, Svensk förening för Innovativ Kirurgisk 
Teknologi), which also appoints the members of the GallRiks board. GallRiks is administered by the Uppsala 
Clinical Research Center (UCR), which is a national center of excellence for quality control registers. An 
increasing number of Swedish hospitals have joined GallRiks since its inception, and 72 hospitals are 
currently affiliated with GallRiks, including all 9 university hospitals, all 21 county hospitals, and 42 small 
county hospitals. This corresponds to almost all hospitals in Sweden. 
 
Data coverage: 
The coverage of the presented data represents 75% of all ERCPs performed in Sweden in the year 2007 and 
more than 87% during the period 2008-2009. The coverage was estimated by cross-linkage to the Swedish 
Hospital Discharge registry (Slutenvårdsregistret) in which the Swedish National Board of Health and 
Welfare has been collecting information on individual hospital discharges since 1965 [Persson et al. 2010]. 
GallRiks is also linked to the registry of Causes of Death (Dödsorsaksregistret).  
 
Data completeness: 
A validation program has been instituted with periodic audits at each institution at least every third year. So 
far, the results from the first 25 audited hospitals indicate a complete match between the medical records and 
the GallRiks data base in 97.3% of ERCP cases [Enochsson et al. 2010].  
 
Data registration: 
The GallRiks registry uses an internet platform (www.ucr.uu.se/gallriks) with online data registration of 
ERCPs and cholecystectomies. The online questionnaire allows over 100 different variables to be described 
for each case with multiple choice functions depending on the complexity of the procedure. Compulsory data 
include patient characteristics, the indication for ERCP, mode of admission, type of anesthesia, cannulation 
technique, diagnostic findings, therapeutic measures in biliary-pancreatic ducts, procedure time, and per-
procedural complications. Data is recorded prospectively by the endoscopist at the time of the procedure. The 
questionnaire is closed after registration of each individual case, and further alterations of the index 
information is not readily possible. Follow-up data is collected locally 30 days after the ERCP by each 
institution, usually by an appointed coordinator. 
 
3.4.3 Study Base 
We identified all patients in whom ERCP was performed for the first time (i.e. on a non-sphincterotomised 
papilla) between January 1, 2007, and December 31, 2009. All patients registered as having PEP were 
considered cases in the analyses, while all registered ERCP patients without a registered PEP were classified 
as control subjects. The complete cohort was further analysed with respect to sex, age, comorbidity, 
indication for ERCP, RV-ERCP and pre-cut assisted cannulation techniques, therapy, procedure time, and 
hospital volume. 
 
3.4.4 Definition of variables and outcome measures 
 
Post-ERCP pancreatitis 
The diagnosis of PEP was defined according to the 1991 Consensus Guidelines and was recorded at the time 
of the 30-day follow-up. However, severity of PEP is not recorded in GallRiks.  
 
Rendezvous cannulation 
Biliary cannulation with rendezvous technique is achieved by using an existing guidewire that has been 
introduced in an antegrade fashion by PTC technique or at cholecystectomy. Basically there are three 
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different approaches, all of which were described previously in detail, figures 12-17.  In GallRiks, however, 
there is no way to distinguish between the various rendezvous techniques mentioned above.  
 
Conventional ERCP cannulation 
Conventional ERCP cannulation techniques see figures 2-4 and 9 and pre-cut cannulation techniques see 
figures 6-7 and 10-11, have been described in detail in a previous chapter:  
 
Statistical analyses 
The quantitative variables were calculated as mean ± standard deviation [SD], and the categorical variables as 
frequencies and/or percentages. The chi-square test was used except in cases where the expected frequencies 
were low, when the Fisher's Exact Test was used instead.  
Odds ratios (OR) and their 95% CI, derived from unconditional logistic regression, were used to assess the 
association between the potential risk factors under study and the risk of PEP, registered 30 days after the 
procedure. Linear trends of the association were tested in a multivariate model by treating categorical 
variables as continuous.  
 
Any potential confounding effects of the variables under study were tested by introducing them one by one 
into the multivariate logistic regression model, and exposures shown to be significant in the univariate 
analysis were tested for possible statistical interactions. The level of statistical significance was specified to be 
0.05, and the fit of the model was tested. 
 
 45 
4 RESULTS 
 
4.1 PAPER I 
Basic characteristics 
During the period of two years, a total of 674 patients underwent cholecystectomy because of cholelithiasis.  
Of these, 612 (90.8%) patients were completed as laparoscopic procedures. Conversion from LC to open 
cholecystectomy occurred in 37 (5.5%) patients. Another 25 (3.7%) patients were electively initiated as open 
cholecystectomies. A total of 592 (87.8%) IOC was completed. Of all the 674 patients, 54 (8.0%) patients 
turned out to have radiological evidence of CBDS, and in 34 (5.0%) of those RV-ERCP was conducted with 
intention to treat. There were 20 (3.0%) patients with CBDS, managed otherwise (laparoscopic transcystic 
approach, n=2; open surgery, n=5; post-operative ERCP, n=13).  
 
Baseline characteristics are outlined in table 1, see Paper I. Gender and age profiles were about the same 
between the two groups, with a domination of female sex (cholecystectomy group 70.9% versus RV-ERCP 
82.4%), and the mean age was close to 48 years. However, there was a significant difference between the 
groups with respect to whether the procedure was planned or performed under acute admission. RV-ERCP 
was performed to a larger degree under conditions in which patients were admitted acutely compared with the 
cholecystectomy group (LC group 19% versus RV-ERCP 35%).  
 
Peroperative data 
The total operating time was significantly extended by an average of 82 minutes when RV-ERCP was 
performed. However, the average operation time decreased considerately after the first year of observation, 
from 216 minutes to 166 minutes, which to a large extent can be explained by the learning curve and 
improved logistical routines. For patients undergoing cholecystectomy without ERCP, the operation time of 
110 minutes was consistent throughout the study period. 
 
Successful cystic duct cannulation during RV-ERCP was completed in all 34 (100%) patients, which was a 
prerequisite for performing IOC for the detection of common bile duct stones. All 34 (100%) patients had 
deep biliary cannulation, and in 26 out of 34 (76%) it was a complete RV-ERCP. Complete stone clearance 
with sphincterotomy and balloon extraction of a visible stone was obtained in 29 (93.5%) of 31 patients. In 
three patients, the endoscopist was not sure whether he actually saw the stone or not during the extraction 
procedure. Complete duct clearance was accomplished in 32 (94.1%) of the 34 patients; the other two (1.9%) 
patients were completed successfully after a second ERCP (one patient with multiple stones and one patient 
with a solitary large difficult common bile duct stone). No peroperative complications were observed when 
RV-ERCP was added to the operation, and all 34 operations could be completed as laparoscopic procedures. 
No clinical signs of PEP were reported among the 34 patients. 
 
Postoperative data 
Adding an ERCP to the laparoscopic cholecystectomy did not significantly affect the average length of 
hospitalization, which was 2.6 ± 0.4 days (median value 2, range 1-9) for the RV-ERCP group, compared 
with 2.1 ± 0.1 days (median value 1, range 1-43) in the cholecystectomy group. Readmission due to 
complications was observed in one (2.9%) patient in the RV-ERCP group, compared with a readmission rate 
of 11.3% in the cholecystectomy group. 
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4.1.1 Comments 
We could show that RV-ERCP was feasible under routine conditions in a clinical setting. Even though the 
average operation time was extended compared with cholecystectomy alone, the procedure itself did not have 
any negative effects concerning the outcomes of complication rate, success rate or duration of hospitalization 
compared with cholecystectomy alone. The unchanged length of hospitalization can probably be attributed to 
the fact that RV-ERCP can be conducted under the principle of minimal invasive surgery as a one-stage 
procedure. At our study point in 2004, our data was on par with other case-series reports by Tatulli et al. 
[Tatulli et al. 2000], Filauro et al. [Filauro et al. 2000] and Tricarico et al. [Tricarico et al. 2002] who used 
the same RV-ERCP approach as we did.  
 
When IOC was used, the indication for ERCP became highly specific. For instance, in almost half of the 
cases with positive findings of CBDS, IOC revealed clinically unexpected stones. Unfortunately, we did not 
have any information on the number of patients who had a preoperative suspicion of common bile duct stones 
that later proved to have a clean IOC. However, a prospective randomized controlled trial by Rábago et al. 
[Rábago et al. 2006] that compared two-stage versus single-stage treatment showed that 57.6% of all patients 
with a preoperative suspicion of common bile duct stones (according to clinical features, liver function tests 
and ultrasound) turned out to have a completely normal IOC. These two examples illustrate how 
unpredictablel common bile duct stones can appear and disappear at the time of surgery and underlines how 
essential it is to have a functional routine in daily practice when stones are frequently detected incidentally.  
 
Weak points of our investigation and other previous reports were the retrospective design of the study and the 
relatively small sample size. So, in that respect, we cannot draw any conclusions from the observation that we 
virtually had no cases of PEP. However, that finding generated our next hypothesis that antegrade rendezvous 
cannulation might prevent pancreatic injury (see Paper III).  
 
 
4.2  PAPER II 
 
Basic characteristics 
A cohort of 44 patients was identified who were treated with mother-baby endoscopy assisted intraductal 
lithotripsy during a period of 10 years. The distribution between genders was equal (22 female/22 male). The 
mean age (74 years) was remarkably high among the patients, and 50% of the patients were 80 years old or 
older. The medical history of a majority of the patients included a substantial number of co-morbidities, and 
nearly half of the cohort had a poor physical status (ASA class 3 or worse) with an overall average physical 
ASA-class status of 2.3. Moreover, 6 (14%) patients were considered too poor in their physical status to 
undergo any general surgery. At the time of the lithotripsy treatment, all 44 patients had undergone at least 
two (range 2-9) unsuccessful conventional ERCP investigations, and 43 (98%) patients had a need for 
permanent biliary drainage due to previously suffering from recurrent biliary symptoms including jaundice 
(87%), abdominal pain (75%) and cholangitis (20%).  
 
Peroperative data 
By the end of the treatment period, complete duct clearance had been achieved in 34 (77%) patients and had 
failed in 10 (23%) patients. In the subgroup of patients who were 80 years of age or older, 19/22 (86%) were 
stone free at the end of the treatment period. The median diameter of the stones was 15 mm, and 72% of the 
stones had a diameter larger than 15 mm. In two-thirds of the cases, the stones were solitary, and the majority 
(86%) were located in the CBD. Total duct clearance after complete or partial fragmentation was obtained in 
half of the cases on the first attempt and another quarter of the cohort became stone free after an additional 
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ERCP session. There was no difference in the success of fragmentation whether EHL or laser lithotripsy was 
performed. The median duration of the procedures was 120 min (range 25-210 min).  
 
 
Postoperative data 
 
Early complications were observed in four (9%) patients. One patient died unexpectedly of myocardial 
infarction at home 10 days after a successful LL with complete ductal clearance and without signs of 
complications associated to the procedure. Another three early post-procedural complications occurred; acute 
cholangitis (n=2) and mild post-ERCP pancreatitis (n=1). The patient flow chart and rate of stone clearance is 
depicted in figure 20. 
 
 
 
Long-term follow-up evaluation  
The remaining 43 patients (the early death mentioned above has been excluded) were followed up for a 
median of 53 months (range 9-126 months). At the end of the follow-up, 13 patients had died at a median age 
of 84 years, approximately 50 months (median value) after the index treatment and with a range of 12 to 88 
months. The causes of death were not related to biliary disease. At completion of the study, the median age of 
the 30 patients still living was 83 years (range 43-95 years) and 6 (14%) patients had experienced late biliary 
symptoms or complications (cholangitis n=2, cholecystitis n=1, suspicion of recurrent stone n=3), events that 
occurred within the first two years after the index procedure. In the cohort of patients with an age of 80 or 
more who had a successful CBDS clearance, all remained free from biliary symptoms after an average of 45 
months follow-up until death or the end of the study period. 
 
48 
4.2.1 Comments 
The current study included virtually all cases of mother-baby-assisted lithotripsy performed in Sweden 
between 1995 and 2006, and our case series also represents the first Scandinavian report. It is important to 
stress that cases of difficult CBDS, resistant to first and second line treatment modalities, are very rare. They 
represent the most complex segment of endoscopic management of CBDS. Moreover, the population 
suffering from giant CBDS contains a disproportionate number of older patients and age-related co-
morbidities. 
 
We showed that clear visualization of the stone and close contact with the lithotriptor probe are prerequisites 
for successful fragmentation and subsequent stone clearance. Gigantic stones, greater than 20 mm in 
diameter, were undoubtedly the most difficult to handle. In eight of the ten failures recorded, the diameter was 
20 mm or larger, although complete stone removal was obtained for 60% of the 20 patients with stones that 
size. Repeated sessions were necessary in a quarter of the cases in order to obtain complete ductal clearance. 
If fragmentation failed completely on the first attempt, the chance to succeed in a subsequent attempt was 
poor; only one (13%) out of eight became stone free. If partial fragmentation was achieved, the rate of success 
at a second endoscopic attempt was 50%. We had an overall stone clearance rate of 77%, which is on par with 
other larger case series [Arya et al. 2004, Adamek et al. 1996, Neuhaus et al. 1993, Hui et al. 2003]. 
However, our cohort represented the oldest patient group ever reported, with an average age of 74 years and a 
median age of 80 years.   
 
Case series like this one, in which a number of patients undergo a treatment and are observed without any 
control group or selection by randomization, is generally considered to be a weaker form of scientific 
evidence. On the other hand, there is no reason to discount the data simply because it is from a retrospective 
study. A well-conducted retrospective study can add important scientific information, and in this particular 
case, it would have been more or less impossible to use a prospective randomized design for a trial like this, 
since this particular situation is extremely rare.  
 
Since the cases were admitted and treated at two different sites, there may be a potential risk of both selection 
bias and misclassification bias. A difficult stone at one hospital might be a non-difficult stone at another. On 
the other hand, all patients in the cohort had undergone one or several ERCP attempts at their home hospital 
before they were referred to our hospitals, and we consistently tried conventional methods before we 
scheduled the patient for a mother-baby-endoscopy. One should also be aware that it is not always a matter of 
stone size that makes a stone difficult to handle; there are other contributing factors such as strictures, the 
anatomic location of the stone and miscellaneous technical aspects.  
 
Another source of bias is the process of determining whether a stone was divided into pieces completely or 
partly. All imaging (X-ray and endoscopy pictures) were investigated by radiologists before and after 
treatment. A standard was decided: stones that were reduced up to 50% in size were to be categorized as 
partly fragmented, and complete fragmentation was obtained if destruction of the stone was more than 50% of 
its size. The arbitrary threshold was found to be meaningful in the sense that patients who were judged as 
having complete fragmentation all became stone free, while partially fragmented stones needed 
complementary ERCP to a greater extent (60%) to obtain duct clearance, and clearance failed in two cases 
(14%). Cases, in which the stone was undistorted, with an exception of a small chip, were classified as failed 
fragmentation. One possible source of error that we could not control was whether there could have been a 
change in the stone's physical strength as a result of pressure energy, but this does not seem to have affected 
the outcome in our limited series.  
 
The strength of this study was its demonstration that it is sensible to treat even very old, frail patients and the 
data showing that patients over 80 years old can continue to live many years without experiencing late biliary 
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symptoms. There is also an example of how endoscopy can offer proper therapeutic intervention of a surgical 
nature for patients who are not eligible for conventional surgical treatment because of medical reasons.  
 
 
4.3 PAPER III 
Basic characteristics 
 
In total, 139 patients were enrolled in the study; another 17 patients were excluded for various reasons shown 
in the flowchart, figure 21.  Relevant preoperative demographic characteristics did not differ between the 
three study groups in terms of gender, BMI, physical status according to ASA classification, baseline 
laboratory values for CRP, pancreatic amylase, proCAPB, or trypsinogen-2. However, there was a difference 
in age, with the conventional ERCP group being somewhat older. In addition, there was, as expected, a 
difference between the control group and the other two groups with respect to bile duct diameter, ALP, and 
bilirubin levels but no significant difference between the rendezvous and conventional ERCP group.  
 
 
 
 
 
Peroperative data 
 
In the RV-ERCP group, transcystic antegrade biliary cannulation was successful in all 40 (100%) patients 
compared with the 38 (93%) successful retrograde cannulations in the ERCP group, which had three (7%) 
failures due to difficult cannulations. Unintentional injection of contrast medium into the pancreatic main duct 
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was observed in 11 (27%) of the conventional ERCP cases compared to no patients in the RV-ERCP group. 
Complete CBDS clearance at the index procedure was achieved in 38 (95%) of the RV-ERCP procedures 
versus 29 (71%) patients in the conventional ERCP group (p=0.01), even though there was no significant 
difference in stone size (p=0.40) or procedure time (p=0.11) between the two study groups. After an 
additional ERCP, the bile ducts in all patients, including the three cases with initial cannulation failure, were 
clear of retained CBDS. None of the 41 patients in the control group had pancreatic duct opacification during 
cholangiography, acute pancreatitis, or hyperamylasemia. 
 
Postoperative data 
 
PEP developed in three (7%) of the 41 patients cannulated with conventional ERCP, compared with no cases 
among patients cannulated by RV-ERCP (p=0.24). According to the Cotton criteria [Cotton et al. 1991], one 
of these cases of pancreatitis was classified as moderate and two as mild. Two major postoperative 
complications were recorded in the LC group: one patient had postoperative intraabdominal bleeding that was 
treated by conservative means and one had postoperative bile leakage from the cystic duct, which was 
successfully treated by temporary endoscopic stent placement. 
 
Laboratory markers 
The post-procedural time course of pancreatic amylase, procarboxypeptidase B and trypsinogen-2 are 
depicted in the three figures below. In the patients treated with conventional ERCP, a significant increase in 
all three markers was seen after 4 hours and levels remained elevated during the entire observation period. 
Patients treated with RV-ERCP had virtually the same trend as the control group that underwent 
cholecystectomy alone.  
 
Figure 22-24, demonstrates serum values at all times (0, 4, 8 and 24 hours) and Y-axis values are 
logarithmically transformed. Vertical bars denote 95% CI. P-values indicate differences between 
conventional (CV) ERCP vs. rendezvous (RV) ERCP.  
 
 
 
 
Figure 22.   Pancreatic amylase (microcat/L) 
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Figure 23. Procarboxypeptidase B (nmol/L) 
 
 
 
Figure 24. Trypsinogen-2 (microg/L) 
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4.3.1 Comments 
 
This study showed that transcystic guidewire-assisted rendezvous cannulation at ERCP followed by bile duct 
stone clearance was not associated with post-procedural pancreatic enzyme leakage. This observation 
supports the hypothesis that rendezvous cannulation can prevent the development of post-ERCP pancreatitis. 
Basically, it is the complete avoidance of pancreatic duct contact together with the absence of difficult 
cannulation that makes the profound difference when the antegrade cannulation technique is used instead of 
retrograde cannulation. In fact, inadvertent contrast injection into the pancreatic duct during conventional 
ERCP was the factor most obviously associated with leakage of pancreatic enzymes into the systemic 
circulation and the subsequent risk of developing PEP. 
 
There are inborn methodological difficulties and challenges associated with studies directed towards various 
aspects of ERCP performances and PEP development. In order to estimate an effect of an uncommon event, a 
large cohort of patients is required to achieve sufficient statistical power. According to our own data from 
GallRiks, the average risk of developing PEP is approximately 4%. If this example is used, as the basis for 
designing a RCT, in which we want to demonstrate a significant (p< 0.05) rate reduction of PEP from 4% to 
2%, we would need to recruit a sample size of at least 2300 patients distributed 1:1 in order to reach a 
sufficient statistical power of 80%. No such study has been reported in the literature.  
 
Because clinical trials demand considerable resources, pilot studies are required to guide the formation of the 
final trial design. Therefore, it is vital to use clinically-relevant biochemical markers as surrogate variables of 
the pancreatic inflammatory response. However, the use of surrogate endpoints is controversial, for good 
reason, and there are numerous examples in which surrogate markers have shown benefits from a particular 
treatment but the effects of the treatment later turned out to be non-significant or even harmful [Psaty et al. 
1999].  
 
In order to get a powerful representative surrogate variable, it is crucial to show strong, consistent, 
independent associations from well-validated trials that will support the use of a particular surrogate variable 
as a true risk factor for the outcome. This was one of the reasons that we wanted to use a more relevant and 
valid surrogate variable than pancreatic amylase, which has a rather low specificity around 71% to 98% and a 
sensitivity between 81% to 95% [Yadav et al. 2002]. We chose proCAPB and trypsinogen-2 since both have 
been shown to be stable, early markers of acute pancreatitis and to be superior to lipase and pancreatic 
amylase, especially if the objectives are to distinguish mild from severe pancreatitis [Kylänpää-Bäck et al. 
2002, Kemppainen et al. 1997, Kobayashi et al. 2011, Petersson et al. 2002] and to discriminate PEP from 
other non-pancreatic disorders with an accuracy of 95% to 99% [Müller et al. 2003, Regnér et al. 2008]. The 
latter distinction is essential, because patients in two of our three study groups were subjected to additional 
surgical trauma in the form of laparoscopic cholecystectomy, which might have increased unspecific 
inflammatory responses. 
 
Our first intention was to perform an RCT, which was also an early proposal by the local Ethics Committee. 
We decided to abandon the idea because of ethical considerations that it might be in conflict with the 
statements according to the ethical principles of the Helsinki Declaration and its fifth article: that the well-
being of human subjects should take precedence over the interests of science [Helsinki 2001]. What were the 
arguments for not performing a RCT? First, ERCP is an invasive endoscopic procedure with the potential of 
causing serious adverse events. If we designed a randomized trial with a treatment arm that would lead to a 
sequential procedure, e.g. pre- or postoperative ERCP, it would result in an appreciable amount of negative 
investigations that in turn could result in a number of unnecessary and potentially harmful ERCP-associated 
complications. Second, a study design with a treatment arm that included post-operative ERCP could end up 
with a worst-case scenario with additional surgical CBD exploration if endoscopic biliary cannulation failed. 
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Third, if we designed the study as a one-stage procedure, the conventional ERCP would be conducted in the 
operating theatre during on-going surgery, an environment less suited for conventional ERCP than the 
endoscopy suite. Under such suboptimal circumstances for conventional ERCP, the study would be seriously 
undermined because methods should be compared under optimal conditions for each. Suboptimal conditions 
for ERCP would also put those patients at risk for a higher complication rate associated with difficult 
cannulation.  After we had explained our reasoning, we received full approval of our study design from the 
Ethical Committee who urged us to proceed since they thought that the clinical issue was of great importance.  
 
All patients admitted to our hospital due to cholecysto/choledocholithiasis were considered for inclusion in 
the RV-ERCP group.  Patients admitted because of CBDS who had undergone a previous cholecystectomy 
were invited to participate in the conventional ERCP group. This inclusion procedure created a risk for 
selection bias in that patients selected for laparoscopic cholecystectomy with or without rendezvous ERCP 
were younger than those selected for conventional ERCP, most of whom had already had their gallbladder 
removed. Therefore, age could serve as a possible confounder for the outcome. However, this is 
counterbalanced to a degree by the fact that young age in itself has repeatedly been found to be an 
independent risk factor for PEP [Christensen et al. 2004, Cheng et al. 2006, Loperfido et al. 1998, Freeman 
et al. 2001], whereas older patients may be protected by, for example, age-related pancreatic atrophy 
[Laugier et al. 1991]. Accordingly, this age imbalance is likely to underestimate than overestimate an 
association.  
 
With the type of intervention-based study that we used, it is impossible to conduct the investigation in 
completely blinded fashion, because the performing endoscopist is obviously aware of the group to which the 
patient belongs.  In designing the study, we wished to address the following concern: An endoscopist who is 
performing a conventional ERCP in a preoperative two-step setting or during a cholecystectomy may not 
have the same strong urge or time to use all endoscopic alternatives, such as pre-cut techniques in order to 
achieve successful biliary cannulation compared with the more demanding postoperative situation when there 
is no readily available surgical solution to lean on. Therefore, we only included postoperative ERCP cases in 
our study.  As a result, the endoscopists for the patients in our conventional ERCP group all had the same 
reasons to perform a thorough ERCP and obtain complete stone clearance. Most importantly, this study 
design did not raise the ethical concerns associated with a randomized trial. 
Despite the caveats due to ethical considerations, we achieved the primary goal in this pilot study, which was 
to test the hypothesis that rendezvous cannulation can avoid pancreatic injury.  
 
4.4 PAPER IV 
Basic characteristics 
 
A total of 17,787 patients who had undergone ERCP were identified in the registry.  Of these,  3,337 (18%) 
were not eligible due to previous ERCP with sphincterotomy and 1,732 could not be included because of 
incomplete 30-day follow-up data, figure 25. Thus leaving 12,718 patients for further analysis. Out of those, 
6,982 (55%) were females. Physical status was assessed according to the ASA classification system. Two-
thirds of the patients were classified as ASA class 1-2 before ERCP. A majority (69%) of the patients were 
admitted acutely, and the most common indication for ERCP was common bile duct stones (28%). PEP was 
recorded in 452 (3.6%) of the patients (Table 2 in Paper IV). According to the GallRiks registry, a total of 
455 patients received RV-ERCP, and 274 of these procedures were conducted as a one-step RV-ERCP. The 
other 181 patients were cannulated with one of the two-step RV-ERCP procedures described in chapter 1. 
3.11.  
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Risk factors for post-ERCP pancreatitis 
 
Among the 455 patients in whom rendezvous ERCP cannulation was performed, there was a 50% decrease in 
the risk of PEP compared with patients who were cannulated by conventional means (OR 0.5; 95% CI 0.2-
0.9), see table 1. 
 
There was a dose-dependent increase in the risk of PEP with decreasing age. In the multivariate analysis, 
patients younger than 60 had a risk of developing PEP that was more than twice as high as that of patients 
older than 82 years (OR 2.3; 95% CI 1.7-3.2). Female gender carried a slightly higher risk of PEP (30%) 
compared with men, and this was statistically significant (OR 1.3; 95% CI 1.1-1.6). Physical status did not 
significantly influence the risk of developing PEP, even though there was a trend towards a lower risk of PEP 
with increasing level of co-morbidity. The risk of PEP was higher among patients who were treated electively 
compared with those who were admitted acutely (OR: 1.3; 95% CI 1.1-1.6). The actual technique of the 
endoscopic sphincterotomy, such as pre-cut, did not affect the risk of PEP and biliary stone extraction.  
Biliary stent placement was associated with a significantly lower risk of developing PEP. Long duration of 
the ERCP procedure was associated with an increased risk of PEP, with the point estimates increasing linearly 
with the duration of the procedure. Procedures lasting longer than 40 minutes had a 2.5 times higher risk than 
procedures lasting less than 20 minutes (OR 2.5; 95% CI 1.8-3.5). The annual volumes of ERCP 
examinations per hospital did not afffect the risk of PEP.  
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4.4.1 Comments 
 
This nationwide population-based case-control study showed that RV-ERCP gave a significant (50%) risk 
reduction in PEP. There have been at least 12 published cases series [Tatulli et al. 2000, Filauro et al. 2000, 
Iodice et al. 2001, Borzellino et al. 2010, Tricarico et al. 2002, La Greca et al. 2007, Enochsson et al. 2004, 
Saccomani et al. 2005, Ghazal et al. 2009], including three randomized trials [Lella et al. 2006, Rábago et al. 
2006, Morino et al. 2006], that suggest that RV-ERCP is associated with lower PEP rates. However, our 
study was the first to have a cohort large enough to reach statistical significance. In addition, our study 
minimized the risk of selection bias and therefore had high internal validity, since all previous studies were 
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based on single-center data. Furthermore, the population-based design used also offers high external validity, 
i.e. it is representative of the Swedish population at large. 
In order to address our hypothesis with statistical strength, we collected data from one of the many Swedish 
case-based quality registers; the Swedish Registry for Gallstone Surgery and ERCP (GallRiks). Ideally, case-
control studies are conducted in a well-defined source population, so that individuals (cases) with the disease 
being studied arise in that source population, and individuals without the disease (controls) are a 
representative sample of the same source population. The term nested refers to the situation when the source 
population is well-defined with a known sample size, as in the current source population, which consists of 
patients registered in GallRiks. The calculation gives an Odds ratio that is an estimation of the incidence rate 
ratio in a population without having to obtain individual information on every patient in the population. A 
nested case-control study can be preferable to a full-scale cross-sectional cohort study when the actual disease 
prevalence is low. A nested case-control study also allows evaluation of multiple possible risk factors. 
However, the design only allows us to measure one disease variable (PEP), and the result will provide less 
statistical precision in estimating the true prevalence or incidence compared with a cohort study.  
In the design of any epidemiological study, it is important to control two major errors that can occur: random 
error and systematic error. A way to control random error is by increasing the sample size. With a cohort that 
includes more than 12,000 patients, the numbers are large enough to produce valid precision. Systematic 
errors, on the other hand, can be difficult to identify and are impossible to correct satisfactorily afterwards if 
they are outside a multivariate modeling and remain unchanged regardless of sample size. Selection bias is a 
systematic error due to a non-random sample of a source population that causes some subjects to be less likely 
to be included than others. By using a nested design, we could precisely identify the source population and 
assure that both the cases and controls were selected from the exact same population source. Since the cohort 
represents about 85% of all ERCPs performed in Sweden during the observation period, almost all hospitals 
are represented. Therefore, there is no selection bias with respect to performance level and expertise or center 
volume. All risk group categories for developing PEP are equally represented in the cohort. Moreover, 
limiting the enrollment period to three years minimizes the risk that the results might have been be influenced 
by alterations in the technique or by the introduction of modernized or novel equipment.  
Information bias can arise because the information collected is erroneous. One type of information bias is 
misclassification, which could be the case if there were faulty registrations in GallRiks. From the GallRiks 
validation program, we know that the completeness of information is very high, with an overall mismatch less 
than 3% between GallRiks and medical charts [Persson et al. 2010]. The internet-based design of the 
GallRiks questionnaire helps ensure that the amount of missing data is kept to a minimum since all 
compulsory data must be entered before the internet file can be sent to the registry. Possible non-differential 
misclassification bias for data entered into the GallRiks registry is measurement faults that are not related to 
the outcome of PEP and should be equally distributed between cases and controls. Nevertheless, a recall bias 
is a plausible misclassification bias among patients who had a short episode of mild PEP that could easily be 
neglected at the time of follow-up 30 days later, leaving a group of patients under-diagnosed for mild PEP. 
This experience is also reflected in prospective controlled trials in which PEP incidence is somewhat higher 
compared with the prevalence of PEP recorded in retrospective ERCP studies.  
An important objection to the present design is the lack of stratification between the three different types of 
RV-ERCP procedures presented in the paper. Although they all share the same concept of antegrade 
cannulation, two of them rely entirely on two-stage management with post-operative ERCP that could lead to 
an unintentional pancreatic main duct contact. If the registry could have discriminated between RV-ERCP 
techniques, that might have, at least in theory, strengthened the analysis. 
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Confounding is always a central issue for epidemiologically-designed studies. Confounding can be defined 
simply as confusion or mixing between the variable being investigated and some other factor (the confounder) 
that appears irrelevant but is actually the one that leads to the outcome. The confounding variable must have 
an effect on the outcome to be recognized as a true confounder. In non-experimental studies, the best defence 
strategies against confounding are stratification of variables, using multivariate adjustment in logistic 
regression analysis, and matching. In the current study, we controlled for confounding by multivariate logistic 
regression modelling; introducing identified variables one by one in backward, forward, and stepwise 
exception analyses. When doing this, we did not observe any significant alterations of Odds ratio or 
confidence interval (CI) in risk variables. However, there are some variables in our study that need to be 
discussed. Comorbidity is a well-known confounder in epidemiological research since there is a strong 
association between advanced age and comorbidity. In our study we found that patients in higher age groups 
and those who had a poorer ASA-classification status had a lower risk of developing PEP compared to those 
who were younger and had a better physical status. A speculative conclusion is that it is more dangerous to 
expose a young, healthy pancreas to ERCP compared with one that is old and worn. This fact could support 
our current recommendation that older, more fragile patients with CBDS are best treated with ERCP only. 
Young, healthy patients should be offered, depending on preferences, laparoscopic or laparoendoscopic 
CBDS management as a first-line treatment. The duration of ERCP procedure is another ambiguous variable 
that includes a plurality of factors that may obscure the reason why extended procedure time leads to an 
increased risk of developing PEP. A speculative explanation could be that prolonged cannulation procedure 
due to difficult cannulation may influence the exposure of long investigations.  
Center-related exposure is another variable that is difficult to interpret since it includes everything from the 
skills of individual endoscopists to a different case-mix of patients or differences in the complexity and 
invasiveness of procedures. In Sweden, there are two high-volume hospitals performing more than 500 
ERCPs annually (22% of the total) and 15 intermediate volume hospitals performing 100-500 ERCPs each 
year (56% of the total). The other 22% of ERCPs are done at low-volume hospitals performing less than 100 
ERCPs on annually basis. There are about 177 individual endoscopists report cases to GallRiks. Of these, 8 
(4.5%) endoscopists performs more than 100 ERCPs per year and 55 (31%) endoscopists do fewer than 10 
ERCPs on an annual basis [Enochsson et al. 2010]. With this huge range of different conditions, one might 
expect that there would be differences in outcomes for PEP. Nevertheless, our data are in line with other 
published data [Williams et al. 2007, Colton and Curran 2009, Testoni et al. 2010], since we could not find a 
significant difference in the outcome of PEP between the three categories of hospital volume.  
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5 GENERAL DISCUSSION 
 
New techniques have provided us with a number of different strategies for removing CBDS, and we have 
seen a proliferation of scientific publications in the quest to find the superior or ideal approach. However, 
there seems to be no standard recommendation about how to treat CBDS in conjunction with 
cholecystectomy. In the clinical guidelines published in 2006 by the European Association for Endoscopic 
Surgery (EAES) [Treckman et al. 2006, Paul et al. 2006] and by the British Society of Gastroenterology in 
2008 [Williams et al. 2008], the alternatives given are either an open or laparoscopic approach or ERCP 
performed separately before or after cholecystectomy. These guidelines do not mention combined 
laparoendoscopic RV-ERCP as a viable alternative. Therefore, the central question is whether RV-ERCP 
could challenge the prevailing doctrine. 
 
5.1.1 Is laparoscopic cholecystectomy with rendezvous ERCP superior to open 
cholecystectomy with common bile duct exploration? 
 
In the era of minimally invasive surgery, we must not forget that in most non-Western countries open 
cholecystectomy together with choledochotomy is still regarded as the first-line treatment for CBDS. Even in 
Sweden, the open approach is still a valid and trusted last resort for a limited group of patients when 
minimally invasive approaches appear to be impossible or complex. During almost 30 years of experience 
with minimally invasive surgery, LC has gradually superseded open cholecystectomy as the operation of 
choice for uncomplicated biliary stone cases. Even though open CBD exploration is still regarded as the 
benchmark to which other treatment modalities are compared, it is surprising that there are no published 
studies comparing the outcome of open CBD explorations with laparoscopic CBD exploration. Likewise, 
there are no randomized trials between open common bile duct exploration and peroperative ERCP 
[Gurusamy and Davidson 2010]. The question is whether those studies would ever be conducted, since the 
general opinion is that open CBD exploration is associated with a higher degree of postoperative pain, a 
prolonged hospital stay and recovery, a longer time before normal activity, and a less cosmetically-appealing 
result. There is no evidence to suggest that a surgeon should have any misgivings about proceeding with open 
CBD surgery in order to obtain stone clearance if a laparoscopic or RV-ERCP procedure failed. Nevertheless, 
studies have demonstrated an increased risk of morbidity, mostly post-operative bile leakage into the 
abdominal cavity, when it is necessary to use a T-tube to obtain biliary downstream control [Moreaux 1995]. 
Open operations are associated with higher mortality rates (around 4% to 10%) in elderly patients and may be 
as high as 20% among elderly and frail patients undergoing open biliary emergency procedures [Siegel and 
Kasmin 1997, Gonzales et al. 1997]. These figures contrast with those for laparoscopy and ERCP, where 
advanced age and comorbidity do not seem to be associated with such high rates of mortality [Ceulemans et 
al. 2004].    
 
5.1.2 Is laparoscopic cholecystectomy with rendezvous ERCP superior to 
complete laparoscopic management? 
 
Laparoscopic CBD exploration performed either by a transcystic route or by direct choledochotomy, has 
advantages that are similar to those of RV-ERCP in many respects. For instance, CBDS can be identified at 
IOC and managed with minimally invasive means in a one-step procedure. Indeed, low rates of complications 
have been reported for laparoscopic transcystic CBD exploration, and the length of hospital stay for the 
procedure is about the same as for LC [Strömberg et al. 2008a, Lauter and Froines. 2000]. However, there 
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are a number of reasons why the complete laparoscopic approach is unlikely to become accepted as an 
optimal treatment for choledocholithiasis. The overall stone clearance rate of the complete laparoscopic 
approach is lower than that of RV-ERCP [La Greca et al. 2009]. Even though the laparoscopic approach may 
be an excellent method of choice for handling small, single stones preferably located below the confluence of 
the cystic duct [Lezoche and Paganini 2000], it is not as suitable for handling intrahepatic stones, multiple 
stones, or large common bile duct stones or for exploring a common bile duct that is surrounded by 
inflammation or has a ductal diameter less than 10 mm [Fitzgibbons and Gardner 2001]. In addition, a 
transcystic or transcholedochal approach does not seem to be the best way to manage a situation in which 
there is an unclear peroperative cholangiogram with obscure images of biliary contrast defects or delayed 
transpapillary contrast passage to the duodenum, which are circumstances that are not uncommon. In contrast, 
RV-ERCP provides transpapillary downstream control by sphincterotomy and allows placement of an 
indwelling stent regardless of the pathology involved.  
 
In general, laparoscopic choledochotomy is considered to be a rather complex procedure that requires 
excellence on the part of the surgeon. Surgeons with average skills may encounter situations in which they 
need to either convert the operation to an open choledochotomy or leave a common bile duct stone for a 
precarious post-operative ERCP. Compare this situation with RV-ERCP, which requires the surgeon to bring 
down a transcystic guidewire through the cholangiogram catheter and the endoscopist to perform a facilitated 
ERCP procedure when the guidewire is in place in the duodenum. Both of these steps can be performed by 
non-experts.  
 
Some opinion leaders are reluctant to suggest conventional ERCP in the OR. The most common arguments  
are that it is difficult to conduct ERCP with the patient in a supine position and that it is harder to work if 
some of the customary endoscopic and advanced X-ray equipment is not available. These arguments may be 
valid for conventional ERCP, but the RV-ERCP procedure can be done well even under operating room 
conditions. Another strong argument against using ERCP has been the justifiable fear of causing PEP. 
However, the evidence from our study and others indicates that ERCP-associated injuries of the pancreatic 
gland can be minimized by using rendezvous cannulation and that PEP is more related to the maneuvers used 
to achieve biliary access rather than to patient characteristics or endoscopic experience [La Greca et al. 
2010]. By using the rendezvous concept, the endoscopist will have instant biliary cannulation success on the 
first attempt, regardless of experience [Hong et al. 2006, ElGeidie et al. 2011]. On the other hand, pancreatitis 
has also been reported as a rare complication (<1%) after laparoscopic CBD exploration, possibly as a 
consequence of antegrade instrumentation or dilatation of the papilla [Tranter and Thompson 2002]. A 
further argument against ERCP instead of the laparoscopic approach is the risk of future consequences due to 
biliary sphincterotomy, a concern that now can largely be dismissed, see 1.3.10.  
 
5.1.3 Is laparoscopy cholecystectomy with rendezvous ERCP superior to a two-
stage strategy with pre- or postoperative ERCP? 
 
In many parts of Sweden and other Western countries, when there is a high suspicion of CBDS during the 
preoperative period, the strategy that is currently most widely-used is to ask the endoscopist to perform an 
ERCP. A subsequent LC is usually planned shortly thereafter. This two-stage approach may be convenient for 
the endoscopists and the surgeons because it allows both groups to treat the patients in an environment that is 
tailored to their own needs and routines. However, this may not serve the patients’ best interests. There are 
two small prospective randomized trials [Rábago et al. 2006, Morino et al. 2006] that compared RV-ERCP 
with sequential pre-operative ERCP and found a significantly higher rate of CBDS clearance when RV-ERCP 
was performed. In addition, morbidity (which was dominated by PEP) was almost three-fold higher in the 
patients who were treated with conventional ERCP.  These results are in line with our findings in study III. 
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Regarding the difference between complete laparoscopic management versus sequential ERCP treatment, the 
evidence is stronger. A number of RCTs including a Cochrane report [Martin et al. 2006], showing that the 
outcomes associated with a one-stage laparoscopic CBD approach are comparable to those of sequential 
management by LC and ERCP in terms of efficacy, morbidity and mortality. This seems to apply regardless 
of whether sequential ERCP is performed as a pre-operatively or post-operatively strategy [Rhodes et al. 
1998, Cushieri et al. 1999, Martin et al. 2006]. However, one-stage based strategies are likely to be more cost 
effective with shorter hospital stays compared to two-stage procedures [Urbach et al. 2001].  
Post-operative ERCP in conjunction with LC is usually performed on the basis of a positive IOC. Under such 
circumstances, the yield of finding CBDS is considerately higher, above 70% [Tham et al. 1998]. Even 
though most of the ERCP procedures are successful, there is always a potential risk of cannulation failure or 
unsuccessful stone clearance, which can necessitate a second surgical procedure when adopting a post-
operative ERCP strategy. One particular situation may arise in connection with RV-ERCP. If the surgeon for 
some reason does not manage to introduce the transcystic guidewire, the options are then to either conduct a 
laparoscopic CBD exploration or convert to open surgery. A viable endoscopic alternative could be to 
perform a conventional per-operative ERCP with the intention of obtaining stone clearance or at least a plain 
duodenoscopy to judge, while the patient is still lying on the operating table, whether it is feasible to conduct 
ERCP in a post-operative scenario if cannulation would actually fail and end up in a reoperation.  
 
A final and sometimes overlooked argument is the patient experience and preference. During laparoscopic 
procedures, the patient is totally unaware of the treatment since it is performed under general anesthesia. Pre- 
or post-operative ERCP is often performed under sedation, which can result in serious discomfort for the 
patient and at times be difficult for the endoscopist to control fully. It is also an inconvenience for the patient 
to be treated twice.  
 
5.1.4 Some final arguments for using rendezvous 
 
Implementation of the rendezvous concept in Sweden started on a modest scale, probably in 1997 at Norra 
Älvsborgs Länssjukus (NÄL), a county hospital in Trollhättan [Johanson et al. 1999]. Today, 15 years later, 
more than 30 surgical units in Sweden have adopted RV-ERCP in conjunction with cholecystectomy as the 
method of choice in the management of CBDS. They have come to depend on the way the method treats 
CBDS in a very straight-forward fashion within a reasonable and predictable time frame during 
cholecystectomy.  Some endoscopists have found that when they are challenged by a difficult stone case, it is 
more effective to terminate the ERCP by placing an indwelling stent and then let the surgeon complete the 
cholecystectomy in a reasonable time. The patient can then have a subsequent elective ERCP in the regular 
endoscopy suite to complete the stone removal. Another reason why RV-ERCP can be implemented 
successfully, especially at a county hospital, is that only a small investment is required because only a 
guidewire is needed in addition to the standard equipment for laparoscopy and ERCP. In general one could 
state that the endoscopist experience is usually very positive with RV-ERCP approach because of the 
minimization of some procedural steps, foremost the simple and swift cannulation. To our knowledge, we 
have not seen any report about surgeons and endoscopists who have abandoned RV-ERCP once it is fully 
implemented. 
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6 CONCLUSIONS 
 
The present study provides data to support the following conclusions: 
 
• Difficult CBDS, unmanageable by conventional endoscopic first- and second-line methods, can be 
treated successfully and safely with intraductal EHL or by LL under the guidance of direct 
visualization by a per oral mother-baby cholangioscopy system.  
• Intraductal EHL or LL biliary treatment can be used in old and/or frail patients. A majority of these 
patients can live many years thereafter free from biliary symptoms, with minimized need for 
hospitalization due to biliary symptoms.  
• Elective laparoscopic cholecystectomy with RV-ERCP is a safe and efficient method for removing 
CBDS and can be conducted in a routine clinical setting. Even if the total operation time is 
prolonged, RV-ERCP does not influence hospital stay compared with laparoscopic cholecystectomy 
alone. 
• RV-ERCP minimizes leakage of pancreatic amylase, procarboxypeptidase B and trypsinogen-2 
compared with conventional post- or pre-operative ERCP. The RV-ERCP induced enzyme leakage 
was identical to that after cholecystectomy without ERCP and therefore seems to reduce the risk of 
developing PEP compared with conventional ERCP.  
• It seems that RV-ERCP has all the important qualities that lead to an effective ERCP without causing 
PEP. RV-ERCP provides swift, single-attempt, direct biliary cannulation at all times regardless of the 
appearance of the papilla, and it can be performed in the same way regardless of the endoscopist’s 
skills and level of experience.  
These results concerning RV-ERCP will challenge the current guidelines for treatment of CBDS, at least 
if ERCP is included in the treatment algorithm in conjunction with cholecystectomy. 
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7 PROPOSALS FOR RELATED CLINICAL RESEARCH IN THE 
FUTURE 
 
While it appears that RV-ERCP is safe and efficient, further trials comparing the rendezvous procedure with 
sequential ERCP and complete laparoscopic management are needed. RCT of all forms of laparoscopic 
common bile duct explorations would not only validate our current results but also allow assessment of 
secondary outcomes where current data are inadequate. In terms of future trials and designs, the following 
studies are proposed: 
 
 
• A descriptive presentation of the entire Karolinska experience, comprising of more than 300 RV-ERCP 
procedures. 
 
• A national survey of methods used to treat common bile duct stones in conjunction with laparoscopic 
cholecystectomy.  
 
• A randomized clinical trial of laparoscopic common bile duct exploration (transcystic and/or 
choledochotomy) versus laparoendoscopic ERCP with rendezvous. It would be worthwhile to 
determine whether there are any statistically-significant differences in morbidity, duct clearance, and 
cost effectiveness. 
 
• A randomized controlled trial with intention to treat between patients presenting with small CBDS, for 
example 5-6 mm, treated during LC by any peroperative method compared with leaving the CBDS in 
situ and observing whether the stones pass spontaneously within 6 months. This would help determine 
which CBDS in the smaller size range need to be cleared up front. 
 
• A randomized trial with intention to treat of sequential ERCP in conjunction with laparoscopic 
cholecystectomy compared with one-stage laparoendoscopic ERCP with rendezvous, with particular 
focus on the patients’ experiences and health economy.  
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8 POPULÄRVETENSKAPLIG SAMMANFATTNING 
 
År 2012 kan vi fira att det var 130 år sedan den tyske läkaren Carl Langenbuch i Berlin 1882 utförde 
världshistoriens första kolecystektomi, det vill säga att man på kirurgisk väg tar bort gallblåsan. Patienten, en 
43-årig man, fick dagen efter operationen äran att tillsammans med kirurgen röka cigarr för att fira händelsen 
och samtidigt uttrycka sin tacksamhet över att slippa de kroniska buksmärtor han lidit av under många år till 
följd av gallsten. 
Trots att dagens gallblåseoperationer numera utförs med titthålskirurgi så råder det samma 
grundprincip idag som förr, det vill säga att man avlägsnar organet där gallsten bildas. Gallstenssjukdom kan i 
vår del av världen betraktas som en verklig folksjukdom då mellan 25 till 50 procent av befolkningen förr 
eller senare i livet kommer att utveckla gallsten, och av dessa utgörs två tredjedelar av kvinnor. Lyckligtvis 
känner majoriteten av gallstensbärarna aldrig av några påtagliga symtom och studier har visat att det bara är 
mellan 10 och 40 procent av de drabbade som till slut behöver opereras. Även om det rör sig om låga 
procenttal så representerar siffrorna i det här sammanhanget ett betydande antal patienter och ansenliga 
kostnader, varje år opereras 11 500 personer för gallstenssjukdom i Sverige. 
Den här framlagda avhandlingen kretsar kring den speciella omständighet när gallsten av olika skäl 
anträffas i området som kallas den gemensamma gallgången. Den gemensamma gallgången är den viktiga 
rörformiga förbindelsen mellan levern (där gallan bildas) och tolvfingertarmen, där gallan bidrar till 
matsmältningen. Beroende på förutsättningarna kan sten i den gemensamma gallgången utgöra en direkt fara 
för patienten då tillståndet förutom smärta kan förorsaka leverskada på grund av stopp i gallflödet, 
gallgångsinfektion eller bukspottkörtelinflammation, om en sten täpper till bukspottkörtelgångens mynning 
som anatomiskt sett delar samma utförsmynning som gallgången. 
Gallblåseoperation med titthålsteknik utförs idag som en rutinoperation och tar cirka en timme i 
anspråk att genomföra. Under pågående operation kan man göra en kontraströntgen av gallvägarna, med 
avsikten att bekräfta eller avfärda förekomst av sten i gallgången samt säkerställa anatomin. Skulle det finnas 
tecken på sten i gallgången finns det i princip tre olika strategier att välja mellan: 
Öppen kirurgi är den klassiska operationen där man gör ett större snitt genom bukväggen strax under höger 
revbensbåge, avlägsnar gallblåsan och öppnar den gemensamma gallgången för att bortskaffa stenen. Den här 
tekniken har fördelen att den är kirurgiskt tillförlitlig och ger mycket goda resultat gällande stenfrihet. 
Nackdelen är att den medför en större kroppslig belastning i återhämtningsfasen vilket kan vara besvärande 
för äldre och skörare patienter. Vårdtiden på sjukhus är ofta drygt en vecka längre jämfört med de ett till två 
dygn som titthålsopererade patienter behöver. 
Under 1990-talet introducerades titthålskirurgi med stor framgång och används rutinmässigt vid nio av 
tio gallblåseoperationer. Det finns stora fördelar att använda titthålsteknik, inte minst när det gäller patientens 
tillfrisknande, som kortare vårdtid och ett mer kosmetiskt tilltalande ärr på bukväggen. Viljan att fullända 
titthålsstrategin har också radikalt förändrat sättet att hantera sten i gemensamma gallgången. Men att 
genomföra en komplett utrymning av sten i den gemensamma gallgången med titthålskirurgi är dock tekniskt 
komplicerat och tidskrävande, därtill är resultaten något sämre jämfört med öppen kirurgi, vilket förklarar 
varför denna teknik tillämpas och behärskas av få kirurger i landet. 
Den metod som varit helt dominerande sedan 1990-talet är endoskopisk retrograd cholangio-
pankreatoskopi (ERCP). Det är ett ingrepp där man via munnen för ner ett slangliknande instrument till 
tolvfingertarmen, för att därifrån med en tunn kateter komma in i gallgången, klyva dess förslutningsmuskel 
och avlägsna en gallgångssten. ERCP är i många avseenden ett alldeles utmärkt förfaringssätt för att erhålla 
stenfrihet och har dessutom den stora fördelen, som nämndes ovan, med att klyva den försnävade 
förslutningsmuskeln och därmed undvika att ytterligare stenar ska kunna fastna där. Om misstanke på 
gallgångssten väcks i anslutning till operation kan ERCP utföras före operation (pre-operativ ERCP) 
alternativt efter (post-operativ ERCP).  
64 
Ur logistisk synvinkel har den här strategin varit praktisk både för operatören och för endoskopisten, men 
problematisk för sjukvården då den inneburit ett förlängt vårdbehov, eller två separata vårdtillfällen, 
dessutom, inte alldeles ovanligt, ett onödigt ingrepp för patienten i de fall stenen har försvunnit spontant före 
ERCP-undersökningen. En annan risk, men liten, är att man inte lyckas komma in i gallgången vid den 
efterföljande ERCP-undersökningen, vilket i enstaka fall kan medföra ny operation. 
Men ERCP är inte en ofarlig teknik då en av de mest fruktade komplikationerna är akut buk-
spottkörtelinflammation, eller som den kallas post-ERCP pankreatit (PEP) eftersom den orsakas av ERCP, 
vilket statistiskt sett drabbar ungefär var tjugonde patient. Visserligen visar PEP sig oftast, i nio fall av tio, 
som en mild till måttligt stark men övergående buksmärta, utan framtida skadeverkningar. Om det emellertid 
skulle tillstöta en allvarlig bukspottkörtel-inflammation kan det ske till priset av en okontrollerbar 
inflammatorisk utbredning till många livsviktiga organ, med intensivvårdskrävande organsvikt och i värsta 
fall risk för död. 
Ett av flera syften med denna avhandling var att studera hur man rutinmässigt kan kombinera de båda 
teknikerna för titthålskirurgi och ERCP. Målet med kombinationen är att kunna erbjuda patienter med 
gallgångssten en komplett titthåls- och endoskopi-baserad behandling vid ett och samma narkostillfälle, med 
hög grad av stenfrihet och med reducerad risk för PEP genom så kallad rendezvous-ERCP. Rendezvous 
innebär i det här sammanhanget att kirurgen för ner en tunn ledare via en kateter i gallblåsans gång och 
vidare, via den gemensamma gallgången, ner till tolvfingertarmen. Samtidigt kan ERCP-undersökaren med 
instrument, via munvägen, möta upp i tolvfingertarmen och fånga ledaren (rendezvous), v.g. se figur 12-13. 
Därmed får ERCP-undersökaren direkt tillträde tillgallgången utan kontakt med bukspottkörtelns huvudgång, 
med mindre risk för komplikation. 
I det första delarbetet visades att det gick att kombinera gallblåseoperation med rendezvous-ERCP och 
att det kunde utföras säkert och framgångsrikt på 34 patienter. Resultaten visade att samtliga patienter kunde 
undersökas i gallgången, de flesta patienter (32 av 34) blev stenfria vid första operationstillfället och 
resterande två kunde åtgärdas vid senare tillfälle med vanlig ERCP teknik. När förslutningsmuskeln är kluven 
så är det betydligt lättare och ofarligare att utföra ERCP. Några ERCP-associerade komplikationer, inklusive 
PEP, observerades inte. Visserligen förlängdes arbetstiden på operationssalen men vårdtiden blev den samma 
jämfört med vanlig gallblåseoperation utförd med titthålsteknik.  
Delarbete två var att studera kort- och långtidsresultatet för de patienter som behandlats med ERCP-
teknik i kombination med laser (LL) eller elektrohydrauliskt (EHL) alstrad stötvågsbehandling i gallgången, 
d.v.s. på så stora gallgångsstenar att de inte kunnat behandlas med vanliga ERCP-metoder. I undersökningen 
presenteras tio års samlade erfarenhet på 44 patienter som behandlats med så kallad mother-babyskopi 
assisterad sönderdelning av stora komplicerade stenar i gallgången med LL respektive EHL, v.g. se figur 19. 
Närmare åtta av tio patienter kunde bli helt stenfria, vissa dock först efter upprepade försök. Det unika med 
studien var den mycket höga medelåldern där hälften av patienterna var 80 år eller äldre och där ett flertal 
tidigare hade bedömts vara i allt för dåligt fysiskt skick för att klara av öppen bukkirurgi. Vid uppföljningen, 
som i medeltal skedde omkring fem år efter ingreppet, kunde man summera att majoriteten av patienterna 
under uppföljningstiden levde utan tecken på gallgångsbesvär eller av denna anledning haft behov av ny 
kontakt med sjukvården. 
I det tredje delarbetet gjordes en jämförande pilotstudie mellan 40 patienter som behandlades med 
rendezvous-ERCP och 41 patienter åtgärdade med vanlig ERCP. Hypotesen var att ERCP med rendezvous-
teknik leder till lägre grad av bukspottkörtelskada, beroende på mängden av ERCP-orsakat enzymläckage 
från bukspottkörteln. Mätvärden registrerades för tre enzymer (pankreasamylas, procarboxypeptidase-B och 
trypsinogen-2) fyra, åtta respektive tjugofyra timmar efter behandling och vars halt i blodet befanns vara 
statistiskt säkerställt högre efter vanlig ERCP jämfört med rendezvous-ERCP. Dessa 40 rendezvous-patienter 
hade i stort sett samma enzymprofil som kontrollgruppen på 41 patienter som bara hade genomgått sedvanlig 
gallblåseoperation med titthålskirurgi, d.v.s. bukspottkörteln tycks inte påverkas i nämnvärd utsträckning med 
RV-ERCP. 
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I fjärde delarbetet gjordes en epidemiologisk studie omfattande tre års (2007-2009) registrering i ett 
nationellt kvalitetsregister för gallkirurgi och ERCP (GallRiks), vilket omfattade 12 718 ERCP-
undersökningar, utförda på patienter med tidigare orörd gallgångsmynning och med komplett 30-dagars 
uppföljning. Totalt, för hela gruppen, var risken för PEP 3,6 procent. Det visade sig med god statistisk 
säkerhet att patienter behandlade med rendezvous-ERCP har 50 procent lägre risk för att utveckla PEP 
jämfört med vanlig ERCP-teknik. Den patientgrupp som löper störst risk att drabbas av PEP är patienter som 
är yngre än 62 år, med 130 procent högre risk, jämfört med de patienter som är äldre än 82 år. En annan 
riskgrupp är kvinnor som löper 30 procent större risk jämfört med män. 
Sammanfattningsvis åskådliggjorde dessa delarbeten (studie I, III, IV) att kombinerad titthålsoperation 
av gallblåsan och ERCP med rendezvous-teknik kan genomföras som ett rutinartat ingrepp utan att det tillför 
risker som normalt är associerade med ERCP. Graden av komplett stenfri behandling är i paritet med öppen 
kirurgi, men vårdtiden på sjukhus är den samma som för vanlig okomplicerad gallblåseoperation med 
titthålskirurgi. 
Kombinerad titthålsoperation för gallblåsa och ERCP kräver inte mer avancerad utrustning eller 
kompetens utöver den som krävs för standardkirurgi eller ERCP-endoskopi, vilket borde vara en god 
förutsättning för spridning av ingreppet på såväl universitets-, läns- som länsdels-sjukhus. Den åtgärd som 
krävs är en fungerande logistik mellan ERCP-team och operationsavdelning. Med hänsyn till de 
behandlingsresultat som erhållits i studierna så kan så kan rendezvous-ERCP rekommenderas i samband med 
gallblåseoperation som en förstahandsmetod för patienter med röntgenbekräftat fynd av sten i gallgången. För 
svårbehandlade stora stenar kan mother-babyskopi-assisterad ERCP, med fragmentering av mycket stora 
stenar i gallgången, rekommenderas som behandlingsmetod även för gamla och sköra patienter. 
 
 
 
A gallbladder illustration from Andreas Vesalus (1514-1564). Saunders, J.B. deC. M.& O´Malley, Charles 
Donald, Facs: Cleveland and New York, The world Publ. Comp. 1950 (Hagströmer Medico-Historial 
Library). 
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